Pharmacy and Poisons Board: Applications

History
+
Request History
4 previous requests available
====
Session
+
Session
- Config(array)
  userAgent9c3d2c89526db53b7b69e8c9faa06145
  time1775177426
  countdown10
====
Request
+
Request

Cake Params
- plugin(null)
- controllerapplications
- actionview
- named(empty)
- pass(array)
  0231
- isAjax(false)
Post data

No post data.

Query string

No querystring data.

Cookie

To view Cookies, add CookieComponent to Controller

Current Route
- keys(array)
  0controller
  1action
- options(empty)
- defaults(array)
  plugin(null)
- template/:controller/:action/*
====

Sql Logs

default

Total Time: 49 ms
Total Queries: 54 queries

Query	Affected	Num. rows	Took (ms)	Actions
SELECT COUNT(*) AS `count` FROM `ctr`.`applications` AS `Application` WHERE `Application`.`id` = 231	1	1	1
SELECT `Application`.`id`, `Application`.`user_id`, `Application`.`application_id`, `Application`.`is_child`, `Application`.`trial_status_id`, `Application`.`total_sites`, `Application`.`abstract_of_study`, `Application`.`study_title`, `Application`.`laymans_summary`, `Application`.`short_title`, `Application`.`protocol_no`, `Application`.`reference_no`, `Application`.`version_no`, `Application`.`date_of_protocol`, `Application`.`study_drug`, `Application`.`disease_condition`, `Application`.`product_type_biologicals`, `Application`.`product_type_proteins`, `Application`.`product_type_immunologicals`, `Application`.`product_type_vaccines`, `Application`.`product_type_hormones`, `Application`.`product_type_toxoid`, `Application`.`product_type_chemical`, `Application`.`product_type_medical_device`, `Application`.`product_type_chemical_name`, `Application`.`product_type_medical_device_name`, `Application`.`comparator`, `Application`.`comparator_name`, `Application`.`comparator_registered`, `Application`.`comparator_countries`, `Application`.`ecct_not_applicable`, `Application`.`ecct_ref_number`, `Application`.`email_address`, `Application`.`applicant_covering_letter`, `Application`.`applicant_protocol`, `Application`.`applicant_patient_information`, `Application`.`applicant_investigators_brochure`, `Application`.`applicant_investigators_cv`, `Application`.`applicant_signed_declaration`, `Application`.`applicant_financial_declaration`, `Application`.`applicant_gmp_certificate`, `Application`.`applicant_indemnity_cover`, `Application`.`applicant_opinion_letter`, `Application`.`applicant_approval_letter`, `Application`.`applicant_statement`, `Application`.`applicant_participating_countries`, `Application`.`applicant_addendum`, `Application`.`applicant_fees`, `Application`.`applicant_complete_form`, `Application`.`applicant_impd`, `Application`.`applicant_prev_data`, `Application`.`applicant_stability_data`, `Application`.`applicant_analysis_cert`, `Application`.`applicant_pictorial_sample`, `Application`.`applicant_gcp_training`, `Application`.`applicant_dsmb_charter`, `Application`.`applicant_detailed_budget`, `Application`.`applicant_indemnity_pi`, `Application`.`applicant_practice_license`, `Application`.`applicant_registration_ctr`, `Application`.`applicant_pan_african`, `Application`.`applicant_hard_copies`, `Application`.`applicant_signed_checklist`, `Application`.`statistical_analysis_plan`, `Application`.`applicant_contractual_agreement`, `Application`.`declaration_applicant`, `Application`.`declaration_date1`, `Application`.`declaration_principal_investigator`, `Application`.`declaration_date2`, `Application`.`placebo_present`, `Application`.`study_objectives`, `Application`.`principal_inclusion_criteria`, `Application`.`principal_exclusion_criteria`, `Application`.`primary_end_points`, `Application`.`scope_diagnosis`, `Application`.`scope_prophylaxis`, `Application`.`scope_therapy`, `Application`.`scope_safety`, `Application`.`scope_efficacy`, `Application`.`scope_pharmacokinetic`, `Application`.`scope_pharmacodynamic`, `Application`.`scope_bioequivalence`, `Application`.`scope_dose_response`, `Application`.`scope_pharmacogenetic`, `Application`.`scope_pharmacogenomic`, `Application`.`scope_pharmacoecomomic`, `Application`.`scope_others`, `Application`.`scope_others_specify`, `Application`.`trial_human_pharmacology`, `Application`.`trial_administration_humans`, `Application`.`trial_bioequivalence_study`, `Application`.`trial_other`, `Application`.`trial_other_specify`, `Application`.`trial_therapeutic_exploratory`, `Application`.`trial_therapeutic_confirmatory`, `Application`.`trial_therapeutic_use`, `Application`.`design_controlled`, `Application`.`site_capacity`, `Application`.`staff_numbers`, `Application`.`other_details_explanation`, `Application`.`other_details_regulatory_notapproved`, `Application`.`other_details_regulatory_approved`, `Application`.`other_details_regulatory_rejected`, `Application`.`other_details_regulatory_halted`, `Application`.`estimated_duration`, `Application`.`design_controlled_randomised`, `Application`.`design_controlled_open`, `Application`.`design_controlled_single_blind`, `Application`.`design_controlled_double_blind`, `Application`.`design_controlled_parallel_group`, `Application`.`design_controlled_cross_over`, `Application`.`design_controlled_other`, `Application`.`design_controlled_specify`, `Application`.`design_controlled_comparator`, `Application`.`design_controlled_other_medicinal`, `Application`.`design_controlled_placebo`, `Application`.`design_controlled_medicinal_other`, `Application`.`design_controlled_medicinal_specify`, `Application`.`single_site_member_state`, `Application`.`location_of_area`, `Application`.`single_site_physical_address`, `Application`.`single_site_contact_person`, `Application`.`single_site_telephone`, `Application`.`multiple_sites_member_state`, `Application`.`multiple_countries`, `Application`.`multiple_member_states`, `Application`.`number_of_sites`, `Application`.`multi_country_list`, `Application`.`data_monitoring_committee`, `Application`.`total_enrolment_per_site`, `Application`.`total_participants_worldwide`, `Application`.`population_less_than_18_years`, `Application`.`population_utero`, `Application`.`population_preterm_newborn`, `Application`.`population_newborn`, `Application`.`population_infant_and_toddler`, `Application`.`population_children`, `Application`.`population_adolescent`, `Application`.`population_above_18`, `Application`.`population_adult`, `Application`.`population_elderly`, `Application`.`gender_female`, `Application`.`gender_male`, `Application`.`subjects_healthy`, `Application`.`subjects_patients`, `Application`.`subjects_vulnerable_populations`, `Application`.`subjects_women_child_bearing`, `Application`.`subjects_women_using_contraception`, `Application`.`subjects_pregnant_women`, `Application`.`subjects_nursing_women`, `Application`.`subjects_emergency_situation`, `Application`.`subjects_incapable_consent`, `Application`.`subjects_specify`, `Application`.`subjects_others`, `Application`.`subjects_others_specify`, `Application`.`investigator1_given_name`, `Application`.`investigator1_middle_name`, `Application`.`investigator1_family_name`, `Application`.`investigator1_qualification`, `Application`.`investigator1_professional_address`, `Application`.`investigator1_telephone`, `Application`.`investigator1_email`, `Application`.`organisations_transferred_`, `Application`.`number_participants`, `Application`.`notification`, `Application`.`approval_date`, `Application`.`submitted`, `Application`.`deleted`, `Application`.`deleted_date`, `Application`.`deactivated`, `Application`.`date_submitted`, `Application`.`unsubmitted`, `Application`.`initial_date_submitted`, `Application`.`admin_stopped`, `Application`.`admin_stopped_reason`, `Application`.`approved`, `Application`.`approved_reason`, `Application`.`approved_date`, `Application`.`final_report`, `Application`.`implication_results`, `Application`.`quantity_imported`, `Application`.`quantity_dispensed`, `Application`.`quantity_destroyed`, `Application`.`quantity_exported`, `Application`.`balance_site`, `Application`.`final_date`, `Application`.`ecitizen_invoice`, `Application`.`modified`, `Application`.`created`, `Application`.`ai_content`, `User`.`id`, `User`.`username`, `User`.`password`, `User`.`confirm_password`, `User`.`name`, `User`.`email`, `User`.`national_id_number`, `User`.`sponsor`, `User`.`sponsor_email`, `User`.`qualification`, `User`.`phone_no`, `User`.`name_of_institution`, `User`.`institution_physical`, `User`.`institution_address`, `User`.`institution_contact`, `User`.`county_id`, `User`.`country_id`, `User`.`group_id`, `User`.`activation_key`, `User`.`forgot_password`, `User`.`is_active`, `User`.`deactivated`, `User`.`created`, `User`.`modified`, `TrialStatus`.`id`, `TrialStatus`.`value`, `TrialStatus`.`name`, `TrialStatus`.`created`, `TrialStatus`.`modified` FROM `ctr`.`applications` AS `Application` LEFT JOIN `ctr`.`users` AS `User` ON (`Application`.`user_id` = `User`.`id`) LEFT JOIN `ctr`.`trial_statuses` AS `TrialStatus` ON (`Application`.`trial_status_id` = `TrialStatus`.`id`) WHERE `Application`.`id` = 231 AND `Application`.`deleted` = '0' LIMIT 1	1	1	1
SELECT `Review`.`id`, `Review`.`user_id`, `Review`.`application_id`, `Review`.`category`, `Review`.`type`, `Review`.`assessment_type`, `Review`.`title`, `Review`.`text`, `Review`.`summary`, `Review`.`recommendation`, `Review`.`notified`, `Review`.`accepted`, `Review`.`conflict`, `Review`.`status`, `Review`.`created`, `Review`.`modified` FROM `ctr`.`reviews` AS `Review` WHERE `Review`.`category` = '0' AND `Review`.`application_id` = (231)	10	10	1	maybe slow
SELECT `InternalReview`.`id`, `InternalReview`.`user_id`, `InternalReview`.`application_id`, `InternalReview`.`category`, `InternalReview`.`type`, `InternalReview`.`assessment_type`, `InternalReview`.`title`, `InternalReview`.`text`, `InternalReview`.`summary`, `InternalReview`.`recommendation`, `InternalReview`.`notified`, `InternalReview`.`accepted`, `InternalReview`.`conflict`, `InternalReview`.`status`, `InternalReview`.`created`, `InternalReview`.`modified` FROM `ctr`.`reviews` AS `InternalReview` WHERE `InternalReview`.`category` = '1' AND `InternalReview`.`application_id` = (231)	2	2	0
SELECT `ActiveInspector`.`id`, `ActiveInspector`.`user_id`, `ActiveInspector`.`application_id`, `ActiveInspector`.`type`, `ActiveInspector`.`assessment_type`, `ActiveInspector`.`title`, `ActiveInspector`.`text`, `ActiveInspector`.`summary`, `ActiveInspector`.`recommendation`, `ActiveInspector`.`notified`, `ActiveInspector`.`accepted`, `ActiveInspector`.`conflict`, `ActiveInspector`.`status`, `ActiveInspector`.`created`, `ActiveInspector`.`modified` FROM `ctr`.`active_inspectors` AS `ActiveInspector` WHERE `ActiveInspector`.`application_id` = (231)	0	0	0
SELECT `ManagerReview`.`id`, `ManagerReview`.`user_id`, `ManagerReview`.`application_id`, `ManagerReview`.`category`, `ManagerReview`.`type`, `ManagerReview`.`assessment_type`, `ManagerReview`.`title`, `ManagerReview`.`text`, `ManagerReview`.`summary`, `ManagerReview`.`recommendation`, `ManagerReview`.`notified`, `ManagerReview`.`accepted`, `ManagerReview`.`conflict`, `ManagerReview`.`status`, `ManagerReview`.`created`, `ManagerReview`.`modified` FROM `ctr`.`reviews` AS `ManagerReview` WHERE `ManagerReview`.`application_id` = (231)	12	12	0
SELECT `Acceptance`.`id`, `Acceptance`.`user_id`, `Acceptance`.`application_id`, `Acceptance`.`category`, `Acceptance`.`type`, `Acceptance`.`assessment_type`, `Acceptance`.`title`, `Acceptance`.`text`, `Acceptance`.`summary`, `Acceptance`.`recommendation`, `Acceptance`.`notified`, `Acceptance`.`accepted`, `Acceptance`.`conflict`, `Acceptance`.`status`, `Acceptance`.`created`, `Acceptance`.`modified` FROM `ctr`.`reviews` AS `Acceptance` WHERE `Acceptance`.`type` = 'acceptance' AND `Acceptance`.`application_id` = (231)	0	0	0
SELECT `Amendment`.`id`, `Amendment`.`application_id`, `Amendment`.`trial_status_id`, `Amendment`.`abstract_of_study`, `Amendment`.`study_title`, `Amendment`.`laymans_summary`, `Amendment`.`protocol_no`, `Amendment`.`version_no`, `Amendment`.`date_of_protocol`, `Amendment`.`study_drug`, `Amendment`.`disease_condition`, `Amendment`.`product_type`, `Amendment`.`product_type_biologicals`, `Amendment`.`product_type_proteins`, `Amendment`.`product_type_immunologicals`, `Amendment`.`product_type_vaccines`, `Amendment`.`product_type_hormones`, `Amendment`.`product_type_toxoid`, `Amendment`.`product_type_chemical`, `Amendment`.`product_type_medical_device`, `Amendment`.`product_type_chemical_name`, `Amendment`.`product_type_medical_device_name`, `Amendment`.`comparator`, `Amendment`.`comparator_name`, `Amendment`.`comparator_registered`, `Amendment`.`comparator_countries`, `Amendment`.`previous_dates`, `Amendment`.`coordinating_investigators`, `Amendment`.`principal_investigators`, `Amendment`.`pharmacist`, `Amendment`.`sponsor_details`, `Amendment`.`gender`, `Amendment`.`details_of_sites`, `Amendment`.`placebos`, `Amendment`.`scopes`, `Amendment`.`organizations`, `Amendment`.`types_and_phases`, `Amendment`.`ecct_not_applicable`, `Amendment`.`ecct_ref_number`, `Amendment`.`email_address`, `Amendment`.`applicant_covering_letter`, `Amendment`.`applicant_protocol`, `Amendment`.`applicant_patient_information`, `Amendment`.`applicant_investigators_brochure`, `Amendment`.`applicant_investigators_cv`, `Amendment`.`applicant_signed_declaration`, `Amendment`.`applicant_financial_declaration`, `Amendment`.`applicant_gmp_certificate`, `Amendment`.`applicant_indemnity_cover`, `Amendment`.`applicant_opinion_letter`, `Amendment`.`applicant_approval_letter`, `Amendment`.`applicant_statement`, `Amendment`.`applicant_participating_countries`, `Amendment`.`applicant_addendum`, `Amendment`.`applicant_fees`, `Amendment`.`declaration_applicant`, `Amendment`.`declaration_date1`, `Amendment`.`declaration_principal_investigator`, `Amendment`.`declaration_date2`, `Amendment`.`placebo_present`, `Amendment`.`study_objectives`, `Amendment`.`principal_inclusion_criteria`, `Amendment`.`principal_exclusion_criteria`, `Amendment`.`primary_end_points`, `Amendment`.`scope_diagnosis`, `Amendment`.`scope_prophylaxis`, `Amendment`.`scope_therapy`, `Amendment`.`scope_safety`, `Amendment`.`scope_efficacy`, `Amendment`.`scope_pharmacokinetic`, `Amendment`.`scope_pharmacodynamic`, `Amendment`.`scope_bioequivalence`, `Amendment`.`scope_dose_response`, `Amendment`.`scope_pharmacogenetic`, `Amendment`.`scope_pharmacogenomic`, `Amendment`.`scope_pharmacoecomomic`, `Amendment`.`scope_others`, `Amendment`.`scope_others_specify`, `Amendment`.`trial_human_pharmacology`, `Amendment`.`trial_administration_humans`, `Amendment`.`trial_bioequivalence_study`, `Amendment`.`trial_other`, `Amendment`.`trial_other_specify`, `Amendment`.`trial_therapeutic_exploratory`, `Amendment`.`trial_therapeutic_confirmatory`, `Amendment`.`trial_therapeutic_use`, `Amendment`.`design_controlled`, `Amendment`.`site_capacity`, `Amendment`.`staff_numbers`, `Amendment`.`other_details_explanation`, `Amendment`.`other_details_regulatory_notapproved`, `Amendment`.`other_details_regulatory_approved`, `Amendment`.`other_details_regulatory_rejected`, `Amendment`.`other_details_regulatory_halted`, `Amendment`.`estimated_duration`, `Amendment`.`design_controlled_randomised`, `Amendment`.`design_controlled_open`, `Amendment`.`design_controlled_single_blind`, `Amendment`.`design_controlled_double_blind`, `Amendment`.`design_controlled_parallel_group`, `Amendment`.`design_controlled_cross_over`, `Amendment`.`design_controlled_other`, `Amendment`.`design_controlled_specify`, `Amendment`.`design_controlled_comparator`, `Amendment`.`design_controlled_other_medicinal`, `Amendment`.`design_controlled_placebo`, `Amendment`.`design_controlled_medicinal_other`, `Amendment`.`design_controlled_medicinal_specify`, `Amendment`.`single_site_member_state`, `Amendment`.`location_of_area`, `Amendment`.`multiple_sites_member_state`, `Amendment`.`multiple_countries`, `Amendment`.`multiple_member_states`, `Amendment`.`number_of_sites`, `Amendment`.`multi_country_list`, `Amendment`.`data_monitoring_committee`, `Amendment`.`total_enrolment_per_site`, `Amendment`.`total_participants_worldwide`, `Amendment`.`population_less_than_18_years`, `Amendment`.`population_utero`, `Amendment`.`population_preterm_newborn`, `Amendment`.`population_newborn`, `Amendment`.`population_infant_and_toddler`, `Amendment`.`population_children`, `Amendment`.`population_adolescent`, `Amendment`.`population_above_18`, `Amendment`.`population_adult`, `Amendment`.`population_elderly`, `Amendment`.`gender_female`, `Amendment`.`gender_male`, `Amendment`.`subjects_healthy`, `Amendment`.`subjects_patients`, `Amendment`.`subjects_vulnerable_populations`, `Amendment`.`subjects_women_child_bearing`, `Amendment`.`subjects_women_using_contraception`, `Amendment`.`subjects_pregnant_women`, `Amendment`.`subjects_nursing_women`, `Amendment`.`subjects_emergency_situation`, `Amendment`.`subjects_incapable_consent`, `Amendment`.`subjects_specify`, `Amendment`.`subjects_others`, `Amendment`.`subjects_others_specify`, `Amendment`.`investigator1_given_name`, `Amendment`.`investigator1_middle_name`, `Amendment`.`investigator1_family_name`, `Amendment`.`investigator1_qualification`, `Amendment`.`investigator1_professional_address`, `Amendment`.`organisations_transferred_`, `Amendment`.`number_participants`, `Amendment`.`notification`, `Amendment`.`approval_date`, `Amendment`.`submitted`, `Amendment`.`date_submitted`, `Amendment`.`modified`, `Amendment`.`created` FROM `ctr`.`amendments` AS `Amendment` WHERE `Amendment`.`application_id` = (231)	4	4	1	maybe slow
SELECT `InvestigatorContact`.`id`, `InvestigatorContact`.`application_id`, `InvestigatorContact`.`given_name`, `InvestigatorContact`.`middle_name`, `InvestigatorContact`.`family_name`, `InvestigatorContact`.`qualification`, `InvestigatorContact`.`professional_address`, `InvestigatorContact`.`telephone`, `InvestigatorContact`.`email`, `InvestigatorContact`.`investigator_role`, `InvestigatorContact`.`created`, `InvestigatorContact`.`modified` FROM `ctr`.`investigator_contacts` AS `InvestigatorContact` WHERE `InvestigatorContact`.`application_id` = (231)	1	1	0
SELECT `ApplicationStage`.`id`, `ApplicationStage`.`application_id`, `ApplicationStage`.`stage`, `ApplicationStage`.`start_date`, `ApplicationStage`.`status`, `ApplicationStage`.`comment`, `ApplicationStage`.`end_date`, `ApplicationStage`.`created`, `ApplicationStage`.`modified` FROM `ctr`.`application_stages` AS `ApplicationStage` WHERE `ApplicationStage`.`application_id` = (231)	7	7	0
SELECT `Pharmacist`.`id`, `Pharmacist`.`application_id`, `Pharmacist`.`reg_no`, `Pharmacist`.`given_name`, `Pharmacist`.`premise_name`, `Pharmacist`.`qualification`, `Pharmacist`.`professional_address`, `Pharmacist`.`valid_year`, `Pharmacist`.`mobile`, `Pharmacist`.`telephone`, `Pharmacist`.`email`, `Pharmacist`.`created`, `Pharmacist`.`modified` FROM `ctr`.`pharmacists` AS `Pharmacist` WHERE `Pharmacist`.`application_id` = (231)	1	1	0
SELECT `EthicalCommittee`.`id`, `EthicalCommittee`.`application_id`, `EthicalCommittee`.`ethical_committee`, `EthicalCommittee`.`submission_date`, `EthicalCommittee`.`erc_number`, `EthicalCommittee`.`initial_approval`, `EthicalCommittee`.`created`, `EthicalCommittee`.`modified` FROM `ctr`.`ethical_committees` AS `EthicalCommittee` WHERE `EthicalCommittee`.`application_id` = (231)	1	1	0
SELECT `AnnualLetter`.`id`, `AnnualLetter`.`application_id`, `AnnualLetter`.`approval_no`, `AnnualLetter`.`type`, `AnnualLetter`.`content`, `AnnualLetter`.`qrcode`, `AnnualLetter`.`approver`, `AnnualLetter`.`approval_date`, `AnnualLetter`.`expiry_date`, `AnnualLetter`.`status`, `AnnualLetter`.`deleted`, `AnnualLetter`.`deleted_date`, `AnnualLetter`.`created`, `AnnualLetter`.`modified` FROM `ctr`.`annual_letters` AS `AnnualLetter` WHERE `AnnualLetter`.`deleted` = '0' AND `AnnualLetter`.`application_id` = (231)	5	5	1	maybe slow
SELECT `AmendmentLetter`.`id`, `AmendmentLetter`.`application_id`, `AmendmentLetter`.`approval_no`, `AmendmentLetter`.`content`, `AmendmentLetter`.`qrcode`, `AmendmentLetter`.`approver`, `AmendmentLetter`.`approval_date`, `AmendmentLetter`.`expiry_date`, `AmendmentLetter`.`status`, `AmendmentLetter`.`submitted`, `AmendmentLetter`.`deleted`, `AmendmentLetter`.`deleted_date`, `AmendmentLetter`.`created`, `AmendmentLetter`.`modified` FROM `ctr`.`amendment_letters` AS `AmendmentLetter` WHERE `AmendmentLetter`.`application_id` = (231)	1	1	0
SELECT `AmendmentApproval`.`id`, `AmendmentApproval`.`application_id`, `AmendmentApproval`.`approval_no`, `AmendmentApproval`.`amendment`, `AmendmentApproval`.`content`, `AmendmentApproval`.`approver`, `AmendmentApproval`.`approval_date`, `AmendmentApproval`.`status`, `AmendmentApproval`.`deleted`, `AmendmentApproval`.`deleted_date`, `AmendmentApproval`.`created`, `AmendmentApproval`.`modified` FROM `ctr`.`amendment_approvals` AS `AmendmentApproval` WHERE `AmendmentApproval`.`application_id` = (231)	1	1	0
SELECT `AmendmentApprovalSummary`.`id`, `AmendmentApprovalSummary`.`application_id`, `AmendmentApprovalSummary`.`approval_no`, `AmendmentApprovalSummary`.`amendment`, `AmendmentApprovalSummary`.`content`, `AmendmentApprovalSummary`.`approver`, `AmendmentApprovalSummary`.`approval_date`, `AmendmentApprovalSummary`.`status`, `AmendmentApprovalSummary`.`deleted`, `AmendmentApprovalSummary`.`deleted_date`, `AmendmentApprovalSummary`.`created`, `AmendmentApprovalSummary`.`modified` FROM `ctr`.`amendment_approvals` AS `AmendmentApprovalSummary` WHERE `AmendmentApprovalSummary`.`status` = 'summary' AND `AmendmentApprovalSummary`.`application_id` = (231)	0	0	0
SELECT `Organization`.`id`, `Organization`.`application_id`, `Organization`.`organization`, `Organization`.`contact_person`, `Organization`.`address`, `Organization`.`telephone_number`, `Organization`.`all_tasks`, `Organization`.`monitoring`, `Organization`.`regulatory`, `Organization`.`investigator_recruitment`, `Organization`.`ivrs_treatment_randomisation`, `Organization`.`data_management`, `Organization`.`e_data_capture`, `Organization`.`susar_reporting`, `Organization`.`quality_assurance_auditing`, `Organization`.`statistical_analysis`, `Organization`.`medical_writing`, `Organization`.`other_duties`, `Organization`.`other_duties_specify`, `Organization`.`misc`, `Organization`.`created`, `Organization`.`modified` FROM `ctr`.`organizations` AS `Organization` WHERE `Organization`.`application_id` = (231)	1	1	0
SELECT `SiteDetail`.`id`, `SiteDetail`.`application_id`, `SiteDetail`.`county_id`, `SiteDetail`.`site_name`, `SiteDetail`.`physical_address`, `SiteDetail`.`contact_details`, `SiteDetail`.`contact_person`, `SiteDetail`.`site_capacity`, `SiteDetail`.`misc`, `SiteDetail`.`created`, `SiteDetail`.`modified` FROM `ctr`.`site_details` AS `SiteDetail` WHERE `SiteDetail`.`application_id` = (231)	1	1	1
SELECT `Placebo`.`id`, `Placebo`.`application_id`, `Placebo`.`placebo_present`, `Placebo`.`pharmaceutical_form`, `Placebo`.`route_of_administration`, `Placebo`.`composition`, `Placebo`.`identical_indp`, `Placebo`.`major_ingredients`, `Placebo`.`created`, `Placebo`.`modified` FROM `ctr`.`placebos` AS `Placebo` WHERE `Placebo`.`application_id` = (231)	1	1	0
SELECT `Sponsor`.`id`, `Sponsor`.`application_id`, `Sponsor`.`sponsor`, `Sponsor`.`sponsor_type`, `Sponsor`.`contact_person`, `Sponsor`.`address`, `Sponsor`.`telephone_number`, `Sponsor`.`fax_number`, `Sponsor`.`cell_number`, `Sponsor`.`email_address`, `Sponsor`.`created`, `Sponsor`.`modified` FROM `ctr`.`sponsors` AS `Sponsor` WHERE `Sponsor`.`application_id` = (231)	1	1	0
SELECT `SiteInspection`.`id`, `SiteInspection`.`application_id`, `SiteInspection`.`user_id`, `SiteInspection`.`reference_no`, `SiteInspection`.`study_title`, `SiteInspection`.`protocol_no`, `SiteInspection`.`version_no`, `SiteInspection`.`pactr_number`, `SiteInspection`.`trial_phase`, `SiteInspection`.`investigators`, `SiteInspection`.`co_investigators`, `SiteInspection`.`study_stage`, `SiteInspection`.`inspection_country`, `SiteInspection`.`inspector_names`, `SiteInspection`.`inspection_dates`, `SiteInspection`.`site_address`, `SiteInspection`.`sponsor_address`, `SiteInspection`.`lab_address`, `SiteInspection`.`events_summary`, `SiteInspection`.`conclusion`, `SiteInspection`.`summary_report`, `SiteInspection`.`outcome`, `SiteInspection`.`approved`, `SiteInspection`.`summary_approved`, `SiteInspection`.`approved_by`, `SiteInspection`.`sent_to_pi`, `SiteInspection`.`deleted`, `SiteInspection`.`deleted_date`, `SiteInspection`.`created`, `SiteInspection`.`modified` FROM `ctr`.`site_inspections` AS `SiteInspection` WHERE `SiteInspection`.`deleted` = '0' AND `SiteInspection`.`application_id` = (231)	3	3	0
SELECT `Sae`.`id`, `Sae`.`application_id`, `Sae`.`sae_id`, `Sae`.`reference_no`, `Sae`.`form_type`, `Sae`.`user_id`, `Sae`.`patient_initials`, `Sae`.`country_id`, `Sae`.`date_of_birth`, `Sae`.`age_years`, `Sae`.`gender`, `Sae`.`causality`, `Sae`.`enrollment_date`, `Sae`.`administration_date`, `Sae`.`latest_date`, `Sae`.`reaction_onset`, `Sae`.`reaction_end_date`, `Sae`.`patient_died`, `Sae`.`prolonged_hospitalization`, `Sae`.`incapacity`, `Sae`.`life_threatening`, `Sae`.`reaction_other`, `Sae`.`reaction_description`, `Sae`.`relevant_history`, `Sae`.`manufacturer_name`, `Sae`.`mfr_no`, `Sae`.`manufacturer_date`, `Sae`.`source_study`, `Sae`.`source_literature`, `Sae`.`source_health_professional`, `Sae`.`report_date`, `Sae`.`report_type`, `Sae`.`approved`, `Sae`.`date_submitted`, `Sae`.`approved_by`, `Sae`.`email_address`, `Sae`.`reporter_name`, `Sae`.`reporter_phone`, `Sae`.`reporter_email`, `Sae`.`deleted`, `Sae`.`deleted_date`, `Sae`.`created`, `Sae`.`modified` FROM `ctr`.`saes` AS `Sae` WHERE `Sae`.`application_id` = (231)	0	0	0
SELECT `Ciom`.`id`, `Ciom`.`application_id`, `Ciom`.`reference_no`, `Ciom`.`user_id`, `Ciom`.`reporter_email`, `Ciom`.`e2b_content`, `Ciom`.`e2b_file`, `Ciom`.`file`, `Ciom`.`dirname`, `Ciom`.`basename`, `Ciom`.`checksum`, `Ciom`.`alternative`, `Ciom`.`group`, `Ciom`.`description`, `Ciom`.`created`, `Ciom`.`modified`, `Ciom`.`deleted` FROM `ctr`.`cioms` AS `Ciom` WHERE `Ciom`.`application_id` = (231)	3	3	0
SELECT `StudyRoute`.`id`, `StudyRoute`.`application_id`, `StudyRoute`.`study_route`, `StudyRoute`.`created`, `StudyRoute`.`modified` FROM `ctr`.`study_routes` AS `StudyRoute` WHERE `StudyRoute`.`application_id` = (231)	1	1	1
SELECT `Manufacturer`.`id`, `Manufacturer`.`application_id`, `Manufacturer`.`manufacturer_name`, `Manufacturer`.`address`, `Manufacturer`.`manufacturer_country`, `Manufacturer`.`manufacturer_phone`, `Manufacturer`.`manufacturer_email`, `Manufacturer`.`manufacturing_activities`, `Manufacturer`.`other_specify`, `Manufacturer`.`created`, `Manufacturer`.`modified` FROM `ctr`.`manufacturers` AS `Manufacturer` WHERE `Manufacturer`.`application_id` = (231)	1	1	0
SELECT `Reassignment`.`id`, `Reassignment`.`application_id`, `Reassignment`.`orig_user`, `Reassignment`.`new_user`, `Reassignment`.`assigning_user`, `Reassignment`.`created`, `Reassignment`.`modified` FROM `ctr`.`reassignments` AS `Reassignment` WHERE `Reassignment`.`application_id` = (231)	0	0	0
SELECT `Attachment`.`id`, `Attachment`.`model`, `Attachment`.`file`, `Attachment`.`foreign_key`, `Attachment`.`dirname`, `Attachment`.`basename`, `Attachment`.`checksum`, `Attachment`.`alternative`, `Attachment`.`group`, `Attachment`.`description`, `Attachment`.`year`, `Attachment`.`file_date`, `Attachment`.`pocket_name`, `Attachment`.`version_no`, `Attachment`.`created`, `Attachment`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Attachment__path` FROM `ctr`.`attachments` AS `Attachment` WHERE `Attachment`.`model` = 'Application' AND `Attachment`.`group` = 'attachment' AND `Attachment`.`foreign_key` = (231)	1	1	2	maybe slow
SELECT `AnnualApproval`.`id`, `AnnualApproval`.`model`, `AnnualApproval`.`file`, `AnnualApproval`.`foreign_key`, `AnnualApproval`.`dirname`, `AnnualApproval`.`basename`, `AnnualApproval`.`checksum`, `AnnualApproval`.`alternative`, `AnnualApproval`.`group`, `AnnualApproval`.`description`, `AnnualApproval`.`year`, `AnnualApproval`.`file_date`, `AnnualApproval`.`pocket_name`, `AnnualApproval`.`version_no`, `AnnualApproval`.`created`, `AnnualApproval`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `AnnualApproval__path` FROM `ctr`.`attachments` AS `AnnualApproval` WHERE `AnnualApproval`.`model` = 'AnnualApproval' AND `AnnualApproval`.`foreign_key` = (231)	1	1	2	maybe slow
SELECT `AmendmentChecklist`.`id`, `AmendmentChecklist`.`model`, `AmendmentChecklist`.`file`, `AmendmentChecklist`.`foreign_key`, `AmendmentChecklist`.`dirname`, `AmendmentChecklist`.`basename`, `AmendmentChecklist`.`checksum`, `AmendmentChecklist`.`alternative`, `AmendmentChecklist`.`group`, `AmendmentChecklist`.`description`, `AmendmentChecklist`.`year`, `AmendmentChecklist`.`file_date`, `AmendmentChecklist`.`pocket_name`, `AmendmentChecklist`.`version_no`, `AmendmentChecklist`.`created`, `AmendmentChecklist`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `AmendmentChecklist__path` FROM `ctr`.`attachments` AS `AmendmentChecklist` WHERE `AmendmentChecklist`.`model` = 'AmendmentChecklist' AND `AmendmentChecklist`.`foreign_key` = (231)	3	3	2	maybe slow
SELECT `Reminder`.`id`, `Reminder`.`foreign_key`, `Reminder`.`model`, `Reminder`.`user_id`, `Reminder`.`reminder_type`, `Reminder`.`created`, `Reminder`.`modified` FROM `ctr`.`reminders` AS `Reminder` WHERE `Reminder`.`model` = 'Application' AND `Reminder`.`foreign_key` = (231)	0	0	0
SELECT `ParticipantFlow`.`id`, `ParticipantFlow`.`application_id`, `ParticipantFlow`.`year`, `ParticipantFlow`.`original_subjects`, `ParticipantFlow`.`consented`, `ParticipantFlow`.`screened`, `ParticipantFlow`.`enrolled`, `ParticipantFlow`.`lost`, `ParticipantFlow`.`lost_reason`, `ParticipantFlow`.`withdrawn`, `ParticipantFlow`.`withdrawal_reason`, `ParticipantFlow`.`self_withdrawal`, `ParticipantFlow`.`self_withdrawal_reasons`, `ParticipantFlow`.`active_subjects`, `ParticipantFlow`.`completed_number`, `ParticipantFlow`.`created`, `ParticipantFlow`.`modified` FROM `ctr`.`participant_flows` AS `ParticipantFlow` WHERE `ParticipantFlow`.`application_id` = (231)	3	3	0
SELECT `Budget`.`id`, `Budget`.`application_id`, `Budget`.`year`, `Budget`.`budget_period`, `Budget`.`personnel_currency`, `Budget`.`personnel`, `Budget`.`transport_currency`, `Budget`.`transport`, `Budget`.`field_currency`, `Budget`.`field`, `Budget`.`supplies_currency`, `Budget`.`supplies`, `Budget`.`pharmacy_currency`, `Budget`.`pharmacy`, `Budget`.`travel_currency`, `Budget`.`travel`, `Budget`.`regulatory_currency`, `Budget`.`regulatory`, `Budget`.`it_currency`, `Budget`.`it`, `Budget`.`lab_currency`, `Budget`.`lab`, `Budget`.`others_currency`, `Budget`.`others`, `Budget`.`kemri_currency`, `Budget`.`kemri`, `Budget`.`wrair_currency`, `Budget`.`wrair`, `Budget`.`subject_currency`, `Budget`.`subject`, `Budget`.`grand_currency`, `Budget`.`grand_total`, `Budget`.`study_information`, `Budget`.`personnel_kshs`, `Budget`.`transport_kshs`, `Budget`.`field_kshs`, `Budget`.`supplies_kshs`, `Budget`.`pharmacy_kshs`, `Budget`.`travel_kshs`, `Budget`.`regulatory_kshs`, `Budget`.`it_kshs`, `Budget`.`lab_kshs`, `Budget`.`others_kshs`, `Budget`.`grand_total_kshs`, `Budget`.`subject_kshs`, `Budget`.`created`, `Budget`.`modified` FROM `ctr`.`budgets` AS `Budget` WHERE `Budget`.`application_id` = (231)	1	1	0
SELECT `Deviation`.`id`, `Deviation`.`application_id`, `Deviation`.`user_id`, `Deviation`.`reference_no`, `Deviation`.`study_title`, `Deviation`.`deviation_type`, `Deviation`.`deviation_type_dev`, `Deviation`.`pi_name`, `Deviation`.`deviation_date`, `Deviation`.`participant_number`, `Deviation`.`treating_physician`, `Deviation`.`deviation_description`, `Deviation`.`deviation_explanation`, `Deviation`.`deviation_measures`, `Deviation`.`deviation_preclude`, `Deviation`.`sponsor_notified`, `Deviation`.`sponsor_notification_date`, `Deviation`.`sponsor_explanation`, `Deviation`.`study_impact`, `Deviation`.`status`, `Deviation`.`date_submitted`, `Deviation`.`deleted`, `Deviation`.`deleted_date`, `Deviation`.`created`, `Deviation`.`modified` FROM `ctr`.`deviations` AS `Deviation` WHERE `Deviation`.`application_id` = (231)	2	2	0
SELECT `Document`.`id`, `Document`.`model`, `Document`.`file`, `Document`.`foreign_key`, `Document`.`dirname`, `Document`.`basename`, `Document`.`checksum`, `Document`.`alternative`, `Document`.`group`, `Document`.`description`, `Document`.`year`, `Document`.`file_date`, `Document`.`pocket_name`, `Document`.`version_no`, `Document`.`created`, `Document`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Document__path` FROM `ctr`.`attachments` AS `Document` WHERE `Document`.`model` = 'Application' AND `Document`.`group` = 'document' AND `Document`.`foreign_key` = (231)	1	1	2	maybe slow
SELECT `CoverLetter`.`id`, `CoverLetter`.`model`, `CoverLetter`.`file`, `CoverLetter`.`foreign_key`, `CoverLetter`.`dirname`, `CoverLetter`.`basename`, `CoverLetter`.`checksum`, `CoverLetter`.`alternative`, `CoverLetter`.`group`, `CoverLetter`.`description`, `CoverLetter`.`year`, `CoverLetter`.`file_date`, `CoverLetter`.`pocket_name`, `CoverLetter`.`version_no`, `CoverLetter`.`created`, `CoverLetter`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `CoverLetter__path` FROM `ctr`.`attachments` AS `CoverLetter` WHERE `CoverLetter`.`model` = 'Application' AND `CoverLetter`.`group` = 'cover_letter' AND `CoverLetter`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Protocol`.`id`, `Protocol`.`model`, `Protocol`.`file`, `Protocol`.`foreign_key`, `Protocol`.`dirname`, `Protocol`.`basename`, `Protocol`.`checksum`, `Protocol`.`alternative`, `Protocol`.`group`, `Protocol`.`description`, `Protocol`.`year`, `Protocol`.`file_date`, `Protocol`.`pocket_name`, `Protocol`.`version_no`, `Protocol`.`created`, `Protocol`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Protocol__path` FROM `ctr`.`attachments` AS `Protocol` WHERE `Protocol`.`model` = 'Application' AND `Protocol`.`group` = 'protocol' AND `Protocol`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `PatientLeaflet`.`id`, `PatientLeaflet`.`model`, `PatientLeaflet`.`file`, `PatientLeaflet`.`foreign_key`, `PatientLeaflet`.`dirname`, `PatientLeaflet`.`basename`, `PatientLeaflet`.`checksum`, `PatientLeaflet`.`alternative`, `PatientLeaflet`.`group`, `PatientLeaflet`.`description`, `PatientLeaflet`.`year`, `PatientLeaflet`.`file_date`, `PatientLeaflet`.`pocket_name`, `PatientLeaflet`.`version_no`, `PatientLeaflet`.`created`, `PatientLeaflet`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `PatientLeaflet__path` FROM `ctr`.`attachments` AS `PatientLeaflet` WHERE `PatientLeaflet`.`model` = 'Application' AND `PatientLeaflet`.`group` = 'patient_leaflet' AND `PatientLeaflet`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Brochure`.`id`, `Brochure`.`model`, `Brochure`.`file`, `Brochure`.`foreign_key`, `Brochure`.`dirname`, `Brochure`.`basename`, `Brochure`.`checksum`, `Brochure`.`alternative`, `Brochure`.`group`, `Brochure`.`description`, `Brochure`.`year`, `Brochure`.`file_date`, `Brochure`.`pocket_name`, `Brochure`.`version_no`, `Brochure`.`created`, `Brochure`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Brochure__path` FROM `ctr`.`attachments` AS `Brochure` WHERE `Brochure`.`model` = 'Application' AND `Brochure`.`group` = 'brochure' AND `Brochure`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `GmpCertificate`.`id`, `GmpCertificate`.`model`, `GmpCertificate`.`file`, `GmpCertificate`.`foreign_key`, `GmpCertificate`.`dirname`, `GmpCertificate`.`basename`, `GmpCertificate`.`checksum`, `GmpCertificate`.`alternative`, `GmpCertificate`.`group`, `GmpCertificate`.`description`, `GmpCertificate`.`year`, `GmpCertificate`.`file_date`, `GmpCertificate`.`pocket_name`, `GmpCertificate`.`version_no`, `GmpCertificate`.`created`, `GmpCertificate`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `GmpCertificate__path` FROM `ctr`.`attachments` AS `GmpCertificate` WHERE `GmpCertificate`.`model` = 'Application' AND `GmpCertificate`.`group` = 'gmp_certificate' AND `GmpCertificate`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Cv`.`id`, `Cv`.`model`, `Cv`.`file`, `Cv`.`foreign_key`, `Cv`.`dirname`, `Cv`.`basename`, `Cv`.`checksum`, `Cv`.`alternative`, `Cv`.`group`, `Cv`.`description`, `Cv`.`year`, `Cv`.`file_date`, `Cv`.`pocket_name`, `Cv`.`version_no`, `Cv`.`created`, `Cv`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Cv__path` FROM `ctr`.`attachments` AS `Cv` WHERE `Cv`.`model` = 'Application' AND `Cv`.`group` = 'cv' AND `Cv`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Finance`.`id`, `Finance`.`model`, `Finance`.`file`, `Finance`.`foreign_key`, `Finance`.`dirname`, `Finance`.`basename`, `Finance`.`checksum`, `Finance`.`alternative`, `Finance`.`group`, `Finance`.`description`, `Finance`.`year`, `Finance`.`file_date`, `Finance`.`pocket_name`, `Finance`.`version_no`, `Finance`.`created`, `Finance`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Finance__path` FROM `ctr`.`attachments` AS `Finance` WHERE `Finance`.`model` = 'Application' AND `Finance`.`group` = 'finance' AND `Finance`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Declaration`.`id`, `Declaration`.`model`, `Declaration`.`file`, `Declaration`.`foreign_key`, `Declaration`.`dirname`, `Declaration`.`basename`, `Declaration`.`checksum`, `Declaration`.`alternative`, `Declaration`.`group`, `Declaration`.`description`, `Declaration`.`year`, `Declaration`.`file_date`, `Declaration`.`pocket_name`, `Declaration`.`version_no`, `Declaration`.`created`, `Declaration`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Declaration__path` FROM `ctr`.`attachments` AS `Declaration` WHERE `Declaration`.`model` = 'Application' AND `Declaration`.`group` = 'declaration' AND `Declaration`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `IndemnityCover`.`id`, `IndemnityCover`.`model`, `IndemnityCover`.`file`, `IndemnityCover`.`foreign_key`, `IndemnityCover`.`dirname`, `IndemnityCover`.`basename`, `IndemnityCover`.`checksum`, `IndemnityCover`.`alternative`, `IndemnityCover`.`group`, `IndemnityCover`.`description`, `IndemnityCover`.`year`, `IndemnityCover`.`file_date`, `IndemnityCover`.`pocket_name`, `IndemnityCover`.`version_no`, `IndemnityCover`.`created`, `IndemnityCover`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `IndemnityCover__path` FROM `ctr`.`attachments` AS `IndemnityCover` WHERE `IndemnityCover`.`model` = 'Application' AND `IndemnityCover`.`group` = 'indemnity_cover' AND `IndemnityCover`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `OpinionLetter`.`id`, `OpinionLetter`.`model`, `OpinionLetter`.`file`, `OpinionLetter`.`foreign_key`, `OpinionLetter`.`dirname`, `OpinionLetter`.`basename`, `OpinionLetter`.`checksum`, `OpinionLetter`.`alternative`, `OpinionLetter`.`group`, `OpinionLetter`.`description`, `OpinionLetter`.`year`, `OpinionLetter`.`file_date`, `OpinionLetter`.`pocket_name`, `OpinionLetter`.`version_no`, `OpinionLetter`.`created`, `OpinionLetter`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `OpinionLetter__path` FROM `ctr`.`attachments` AS `OpinionLetter` WHERE `OpinionLetter`.`model` = 'Application' AND `OpinionLetter`.`group` = 'opinion_letter' AND `OpinionLetter`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `ApprovalLetter`.`id`, `ApprovalLetter`.`model`, `ApprovalLetter`.`file`, `ApprovalLetter`.`foreign_key`, `ApprovalLetter`.`dirname`, `ApprovalLetter`.`basename`, `ApprovalLetter`.`checksum`, `ApprovalLetter`.`alternative`, `ApprovalLetter`.`group`, `ApprovalLetter`.`description`, `ApprovalLetter`.`year`, `ApprovalLetter`.`file_date`, `ApprovalLetter`.`pocket_name`, `ApprovalLetter`.`version_no`, `ApprovalLetter`.`created`, `ApprovalLetter`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `ApprovalLetter__path` FROM `ctr`.`attachments` AS `ApprovalLetter` WHERE `ApprovalLetter`.`model` = 'Application' AND `ApprovalLetter`.`group` = 'approval_letter' AND `ApprovalLetter`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Statement`.`id`, `Statement`.`model`, `Statement`.`file`, `Statement`.`foreign_key`, `Statement`.`dirname`, `Statement`.`basename`, `Statement`.`checksum`, `Statement`.`alternative`, `Statement`.`group`, `Statement`.`description`, `Statement`.`year`, `Statement`.`file_date`, `Statement`.`pocket_name`, `Statement`.`version_no`, `Statement`.`created`, `Statement`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Statement__path` FROM `ctr`.`attachments` AS `Statement` WHERE `Statement`.`model` = 'Application' AND `Statement`.`group` = 'statement' AND `Statement`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `ParticipatingStudy`.`id`, `ParticipatingStudy`.`model`, `ParticipatingStudy`.`file`, `ParticipatingStudy`.`foreign_key`, `ParticipatingStudy`.`dirname`, `ParticipatingStudy`.`basename`, `ParticipatingStudy`.`checksum`, `ParticipatingStudy`.`alternative`, `ParticipatingStudy`.`group`, `ParticipatingStudy`.`description`, `ParticipatingStudy`.`year`, `ParticipatingStudy`.`file_date`, `ParticipatingStudy`.`pocket_name`, `ParticipatingStudy`.`version_no`, `ParticipatingStudy`.`created`, `ParticipatingStudy`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `ParticipatingStudy__path` FROM `ctr`.`attachments` AS `ParticipatingStudy` WHERE `ParticipatingStudy`.`model` = 'Application' AND `ParticipatingStudy`.`group` = 'participating_study' AND `ParticipatingStudy`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Addendum`.`id`, `Addendum`.`model`, `Addendum`.`file`, `Addendum`.`foreign_key`, `Addendum`.`dirname`, `Addendum`.`basename`, `Addendum`.`checksum`, `Addendum`.`alternative`, `Addendum`.`group`, `Addendum`.`description`, `Addendum`.`year`, `Addendum`.`file_date`, `Addendum`.`pocket_name`, `Addendum`.`version_no`, `Addendum`.`created`, `Addendum`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Addendum__path` FROM `ctr`.`attachments` AS `Addendum` WHERE `Addendum`.`model` = 'Application' AND `Addendum`.`group` = 'addendum' AND `Addendum`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Registration`.`id`, `Registration`.`model`, `Registration`.`file`, `Registration`.`foreign_key`, `Registration`.`dirname`, `Registration`.`basename`, `Registration`.`checksum`, `Registration`.`alternative`, `Registration`.`group`, `Registration`.`description`, `Registration`.`year`, `Registration`.`file_date`, `Registration`.`pocket_name`, `Registration`.`version_no`, `Registration`.`created`, `Registration`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Registration__path` FROM `ctr`.`attachments` AS `Registration` WHERE `Registration`.`model` = 'Application' AND `Registration`.`group` = 'registration' AND `Registration`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Fee`.`id`, `Fee`.`model`, `Fee`.`file`, `Fee`.`foreign_key`, `Fee`.`dirname`, `Fee`.`basename`, `Fee`.`checksum`, `Fee`.`alternative`, `Fee`.`group`, `Fee`.`description`, `Fee`.`year`, `Fee`.`file_date`, `Fee`.`pocket_name`, `Fee`.`version_no`, `Fee`.`created`, `Fee`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Fee__path` FROM `ctr`.`attachments` AS `Fee` WHERE `Fee`.`model` = 'Application' AND `Fee`.`group` = 'fee' AND `Fee`.`foreign_key` = (231)	0	0	2	maybe slow
SELECT `Checklist`.`id`, `Checklist`.`model`, `Checklist`.`file`, `Checklist`.`foreign_key`, `Checklist`.`dirname`, `Checklist`.`basename`, `Checklist`.`checksum`, `Checklist`.`alternative`, `Checklist`.`group`, `Checklist`.`description`, `Checklist`.`year`, `Checklist`.`file_date`, `Checklist`.`pocket_name`, `Checklist`.`version_no`, `Checklist`.`created`, `Checklist`.`modified`, (CONCAT_WS('/', dirname, basename)) AS `Checklist__path` FROM `ctr`.`attachments` AS `Checklist` WHERE `Checklist`.`model` = 'Checklist' AND `Checklist`.`foreign_key` = (231)	15	15	2	maybe slow
SELECT `StudyMonitor`.`id`, `StudyMonitor`.`user_id`, `StudyMonitor`.`application_id`, `StudyMonitor`.`amendment_id`, `StudyMonitor`.`owner_id`, `StudyMonitor`.`created`, `StudyMonitor`.`modified` FROM `ctr`.`study_monitors` AS `StudyMonitor` WHERE `StudyMonitor`.`user_id` = (231)	0	0	0
SELECT `ProtocolOutsource`.`id`, `ProtocolOutsource`.`user_id`, `ProtocolOutsource`.`application_id`, `ProtocolOutsource`.`outsource_id`, `ProtocolOutsource`.`owner_id`, `ProtocolOutsource`.`created`, `ProtocolOutsource`.`modified` FROM `ctr`.`protocol_outsources` AS `ProtocolOutsource` WHERE `ProtocolOutsource`.`user_id` = (231)	0	0	0
SELECT `Outsource`.`id`, `Outsource`.`application_id`, `Outsource`.`user_id`, `Outsource`.`model`, `Outsource`.`username`, `Outsource`.`name`, `Outsource`.`email`, `Outsource`.`phone_no`, `Outsource`.`institution_physical`, `Outsource`.`name_of_institution`, `Outsource`.`institution_address`, `Outsource`.`institution_contact`, `Outsource`.`county_id`, `Outsource`.`country_id`, `Outsource`.`approved`, `Outsource`.`created`, `Outsource`.`modified`, `Outsource`.`accepted`, `Outsource`.`model_sae`, `Outsource`.`model_ciom`, `Outsource`.`model_dev` FROM `ctr`.`outsources` AS `Outsource` WHERE `Outsource`.`application_id` = (231)	3	3	0

Query Explain:

Click an "Explain" link above, to see the query explanation.

====

Timer

Memory

Peak Memory Use 16.03 MB

Message	Memory use
Component initialization	2.42 MB
Controller action start	3.61 MB
Controller render start	8.46 MB
View render complete	8.90 MB

Timers

Total Request Time: 190 (ms)

Message	Time in ms	Graph
Core Processing (Derived from $_SERVER["REQUEST_TIME"])	9.86
Event: Controller.initialize	0.29
Event: Controller.startup	0.48
Controller action	97.35
Event: Controller.beforeRender	22.98
» Processing toolbar data	22.83
Rendering View	3.34
» Event: View.beforeRender	0.03
» Rendering APP/View/Applications/view.ctp	0.64
» Event: View.afterRender	0.02
» Event: View.beforeLayout	0.02
» Rendering APP/View/Layouts/default.ctp	2.27
» » Rendering APP/View/Elements/google-analytics.ctp	0.05
Event: View.afterLayout	0.00

====

Log
+

Logs

There were no log entries made this request

====
Variables
+
View Variables
- application(array)
 Application(array)
 id231
 user_id29
 application_id(null)
 is_child0
 trial_status_id6
 total_sites2
 abstract_of_study Sample
 study_title Sample sample
 laymans_summary test
 short_titleTest
 protocol_noECCT/25/07/01
 reference_no
 version_no3
 date_of_protocol11-07-2025
 study_drugSample
 disease_conditionSample
 product_type_biologicals1
 product_type_proteins0
 product_type_immunologicals1
 product_type_vaccines0
 product_type_hormones0
 product_type_toxoid0
 product_type_chemical1
 product_type_medical_device0
 product_type_chemical_namesample
 product_type_medical_device_name
 comparatorYes
 comparator_namesample
 comparator_registeredsample
 comparator_countriessample,sample
 ecct_not_applicable0
 ecct_ref_number
 email_addressjkiprotich@intellisoftkenya.com
 applicant_covering_letter1
 applicant_protocol1
 applicant_patient_information1
 applicant_investigators_brochure1
 applicant_investigators_cv1
 applicant_signed_declaration1
 applicant_financial_declaration1
 applicant_gmp_certificate1
 applicant_indemnity_cover1
 applicant_opinion_letter1
 applicant_approval_letter0
 applicant_statement1
 applicant_participating_countries(null)
 applicant_addendum0
 applicant_fees1
 applicant_complete_form(null)
 applicant_impd0
 applicant_prev_data0
 applicant_stability_data0
 applicant_analysis_cert0
 applicant_pictorial_sample0
 applicant_gcp_training0
 applicant_dsmb_charter0
 applicant_detailed_budget0
 applicant_indemnity_pi0
 applicant_practice_license0
 applicant_registration_ctr(null)
 applicant_pan_african1
 applicant_hard_copies(null)
 applicant_signed_checklist0
 statistical_analysis_plan0
 applicant_contractual_agreement0
 declaration_applicantsample sample
 declaration_date111-07-2025
 declaration_principal_investigatorSample Sample
 declaration_date211-07-2025
 placebo_presentNo
 study_objectives sample sample
 principal_inclusion_criteria saample
 principal_exclusion_criteria sample
 primary_end_points sample
 scope_diagnosis1
 scope_prophylaxis1
 scope_therapy0
 scope_safety0
 scope_efficacy0
 scope_pharmacokinetic0
 scope_pharmacodynamic0
 scope_bioequivalence0
 scope_dose_response0
 scope_pharmacogenetic0
 scope_pharmacogenomic0
 scope_pharmacoecomomic0
 scope_others0
 scope_others_specify
 trial_human_pharmacology1
 trial_administration_humans1
 trial_bioequivalence_study0
 trial_other0
 trial_other_specify
 trial_therapeutic_exploratory1
 trial_therapeutic_confirmatory0
 trial_therapeutic_use0
 design_controlledNo
 site_capacity(null)
 staff_numbers sample sample
 other_details_explanation sample sample
 other_details_regulatory_notapproved sample
 other_details_regulatory_approved sample
 other_details_regulatory_rejected sample
 other_details_regulatory_halted sample
 estimated_duration3
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_stateYes
 location_of_areasample sample
 single_site_physical_addresssample sample
 single_site_contact_personsample
 single_site_telephone0733098232
 multiple_sites_member_stateNo
 multiple_countriesNo
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committeeNo
 total_enrolment_per_site40
 total_participants_worldwide40
 population_less_than_18_yearsYes
 population_uteroNo
 population_preterm_newbornNo
 population_newbornNo
 population_infant_and_toddlerNo
 population_childrenNo
 population_adolescentNo
 population_above_18Yes
 population_adultYes
 population_elderlyYes
 gender_female1
 gender_male1
 subjects_healthyNo
 subjects_patientsNo
 subjects_vulnerable_populationsNo
 subjects_women_child_bearingNo
 subjects_women_using_contraceptionNo
 subjects_pregnant_womenNo
 subjects_nursing_womenNo
 subjects_emergency_situationNo
 subjects_incapable_consentNo
 subjects_specify
 subjects_othersNo
 subjects_others_specify
 investigator1_given_namesample sample
 investigator1_middle_namesample
 investigator1_family_namesample sample
 investigator1_qualificationsample
 investigator1_professional_addresssample
 investigator1_telephone0700543987
 investigator1_emailsample@gmail.com
 organisations_transferred_No
 number_participants30
 notification Sample docs
 approval_date30-09-2025
 submitted1
 deleted0
 deleted_date(null)
 deactivated0
 date_submitted11-07-2025
 unsubmitted0
 initial_date_submitted(null)
 admin_stopped0
 admin_stopped_reason(null)
 approved2
 approved_reasontest
 approved_date(null)
 final_report test
 implication_results test
 quantity_imported3
 quantity_dispensed3
 quantity_destroyed3
 quantity_exported3
 balance_site3
 final_date2025-09-30
 ecitizen_invoice363835
 modified2026-02-17 10:47:21
 created2025-03-27 12:53:06
 ai_content(null)
 User(array)
 id29
 usernamejkiprotich
 password547f0111bc877d5579f28409dcb3dafc5439c785
 confirm_password547f0111bc877d5579f28409dcb3dafc5439c785
 nameJapheth Kiprotich
 emailjkiprotich@intellisoftkenya.com
 national_id_number32645167
 sponsor(null)
 sponsor_emailjkiprotich@intellisoftkenya.com
 qualificationDentist
 phone_no254724743788
 name_of_institution
 institution_physical
 institution_address
 institution_contact
 county_id47
 country_id115
 group_id5
 activation_key
 forgot_password0
 is_active1
 deactivated0
 created2024-01-19 06:00:03
 modified2024-10-16 14:11:49
 TrialStatus(array)
 id6
 valueIn follow-up
 nameIn follow-up
 created2013-10-07 18:20:30
 modified2013-10-07 18:20:30
 Review(array)
 0(array)
 id3
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summaryTrial category comments Earum ipsum in inven Trial phase comments (if in disagreement with the study phase proposed): Consectetur ipsa s Assessor’s discussion on the clinical development: Eligendi lorem inven Clinical Trial Rationale comments Et repudiandae repel Primary objectives comments Beatae commodi adipi Secondary objectives comments Facere est unde dolo Study population comments Sunt dolore volupta Inclusion criteria comments Beatae dolores enim Exclusion criteria comments Possimus consectetu Vulnerable populations comments Optio tenetur nobis Study plan and design comments Suscipit ullamco qui Study treatment comments Porro incidunt veni Comparator IMP(s) comments Saepe dolorem offici Placebo comments Velit exercitation Auxilliary medicinal product(s) comments Deleniti nostrud har Additional considerations comments Atque a velit volupt Safety comments Ea reiciendis dolore Blinding and unblinding comments Atque corporis corpo Contraception measures comments Iusto velit quaerat Discontinuation criteria comments Nesciunt nulla et l Other concomitant comments Et tenetur fuga Eiu Safety and Monitoring comments Velit duis sint dic Reference Safety Information comments Nihil velit eu id o Data Safety Monitoring Committee comments Quia adipisicing per Definition of the end of the trial comments Et voluptas earum ir Biological samples used in the study comments Pariatur Consequunt Data protection comments Ipsum quis maiores a Recruitment and informed consent procedures comment Minim ex sed ratione Comments on the benefit/risk: Aut quaerat pariatur Overall comment/ conclusion on the clinical assessment: Eaque ut quos illo e 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION Cum voluptate est es
 recommendationdone
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-02-06 09:10:11
 modified2026-02-06 09:31:18
 1(array)
 id4
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summaryTrial category comments Consectetur atque ex Trial phase comments (if in disagreement with the study phase proposed): Nam eu dolor labore Assessor’s discussion on the clinical development: Delectus sunt vero Clinical Trial Rationale comments Exercitationem ut es Primary objectives comments Nesciunt cillum lib Secondary objectives comments Ratione sunt dolorem Study population comments Nesciunt nisi maxim Inclusion criteria comments Elit ipsum optio Exclusion criteria comments Incidunt et aut exp Vulnerable populations comments Veritatis saepe simi Study plan and design comments Saepe quo aut quia n Study treatment comments Alias reiciendis ex Comparator IMP(s) comments Omnis a omnis laboru Placebo comments Officia ipsam dolore Auxilliary medicinal product(s) comments Consequat Dolorum v Additional considerations comments Ipsa sunt cumque e Safety comments Eligendi minus praes Blinding and unblinding comments Corporis quos sunt e Contraception measures comments Nam est aperiam dolo Discontinuation criteria comments Et aut culpa laborum Other concomitant comments Cillum inventore non Safety and Monitoring comments Suscipit corporis fa Reference Safety Information comments Nam provident qui v Data Safety Monitoring Committee comments Qui explicabo Ea no Definition of the end of the trial comments Molestiae sapiente c Biological samples used in the study comments Sunt saepe sit vel Data protection comments Nam eos mollit non e Recruitment and informed consent procedures comment Quos voluptates eaqu Comments on the benefit/risk: Dolore reiciendis do Overall comment/ conclusion on the clinical assessment: Fugit laboriosam u 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION Vitae id velit et oc
 recommendationwow
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-02-06 09:31:50
 modified2026-02-06 09:32:45
 2(array)
 id5
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summaryTrial category comments Exercitation quibusd Trial phase comments (if in disagreement with the study phase proposed): Dolore adipisicing v Assessor’s discussion on the clinical development: Suscipit consequatur Clinical Trial Rationale comments Expedita tempore qu Primary objectives comments Nulla quos alias par Secondary objectives comments Assumenda suscipit d Study population comments Laborum Debitis sin Inclusion criteria comments Eius velit ut veniam Exclusion criteria comments Ex ad voluptas ea se Vulnerable populations comments Tempor soluta qui se Study plan and design comments Possimus non id ut Study treatment comments Cupiditate velit ne Comparator IMP(s) comments Incidunt anim sed i Placebo comments Minima cupiditate vo Auxilliary medicinal product(s) comments Qui voluptatem vel v Additional considerations comments Ullamco distinctio Safety comments Aute occaecat quaera Blinding and unblinding comments Magnam architecto eu Contraception measures comments Lorem assumenda veni Discontinuation criteria comments Quod iure veniam mo Other concomitant comments Quis aut repellendus Safety and Monitoring comments Sit voluptas quis ad Reference Safety Information comments Aperiam nobis mollit Data Safety Monitoring Committee comments Ea eveniet necessit Definition of the end of the trial comments Voluptas ea consequu Biological samples used in the study comments Voluptatem vitae min Data protection comments Officia excepteur qu Recruitment and informed consent procedures comment Quod voluptatum quia Comments on the benefit/risk: Dolores maxime volup Overall comment/ conclusion on the clinical assessment: Dolor dolores id fac 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION Praesentium labore o
 recommendation
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-02-06 09:33:24
 modified2026-02-06 09:36:03
 3(array)
 id6
 user_id3
 application_id231
 category0
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation
 notified0
 acceptedaccepted
 conflictNo
 statusUnsubmitted
 created2026-02-06 10:00:00
 modified2026-02-06 10:00:17
 4(array)
 id7
 user_id790
 application_id231
 category0
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-06 10:00:00
 modified2026-02-06 10:00:00
 5(array)
 id8
 user_id3
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-06 10:00:22
 modified2026-03-05 16:35:34
 6(array)
 id9
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typestatistical
 title(null)
 text(null)
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-09 10:02:05
 modified2026-02-09 10:02:05
 7(array)
 id10
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-10 07:42:53
 modified2026-02-10 07:44:37
 8(array)
 id22
 user_id2
 application_id231
 category0
 typeppb_comment
 assessment_type(null)
 title(null)
 text test
 summary(null)
 recommendation test
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-03-05 12:33:51
 modified2026-03-05 12:33:51
 9(array)
 id23
 user_id3
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summary Trial category workspace Cupidatat dolorem mo Trial category comments Qui qui necessitatib Trial phase workspace Odio accusantium do Trial phase comments (if in disagreement with the study phase proposed): Dicta minus cupidita Therapeutic condition workspace Voluptatibus quos et Brief description of the disease Ipsa sunt qui reru Brief discussion of clinical pharmacokinetic data, efficacy and safety data described in the IB from previous trials /previously investigated indications(s) for the IMP(s). Non-clinical studies may also be discussed for early or FIH clinical trials. Consideration should be given to the justification provided based on the non-clinical data, for the proposed starting dose, dose steps, and maximum exposure Enim eaque molestias Assessor’s discussion on the clinical development: Eligendi voluptatem Consider what is new in this trial, the clinical relevance, and the medical need that the trial aims to address Rerum asperiores ips Clinical Trial Rationale comments Culpa eu vel recusa Consider if there are established primary endpoints for this type of study/indication, do they match the goals, are they validated? Itaque praesentium e Primary objectives comments Ad do ipsum eum non Secondary objectives workspace Voluptatibus facere Secondary objectives comments Et sunt sit ad ut ip Study population workspace Deserunt deserunt mo Study population comments Ad nostrum ad provid Take also into consideration the gender and age allocation of participants, and determine whether a specific group is excluded or underrepresented Qui amet qui quia m Inclusion criteria comments Error deserunt et do Check if a justification is provided in the event that a specific group is excluded or underrepresented Applicable for registered products, consider the contraindications included in the SmPC for the investigational medical product, comparator, and auxiliary medical products Nulla accusamus veli Exclusion criteria comments Dolor enim culpa obc The inclusion of vulnerable population is justifiable only if this information cannot be obtained from non‑vulnerable populations For incapacitated or minor participants, the trial should offer some direct benefit to the tem or to the population that they represent Omnis voluptatem ea Vulnerable populations comments Ea et tempore esse Brief description of the study plan and design, and whenever possible, include a diagram/flow chart Discuss the expected duration of the participants' participation and a description of the sequence and duration of all the clinical trial periods, including the follow up Ab cum quasi ut veri Study plan and design comments Dolorem ipsa eaque Consider the dose(s)/dose steps, dose rationale, route of administration, schedule, treatment duration, and dose modifications Nulla suscipit place Study treatment comments Iste accusamus nostr Comparator IMP(s) workspace Labore eius lorem il Comparator IMP(s) comments Explicabo Cum unde Placebo workspace Totam libero iure do Placebo comments Et quia similique do Auxilliary medicinal product(s) workspace Harum tempora quo er Auxilliary medicinal product(s) comments At nostrud et et atq Additional considerations workspace Qui eaque voluptatem Additional considerations comments Ipsum corporis eum q Brief description of the important safety risks associated with trial treatments identified in any previous clinical trials, and as outlined in the IB or SmPC, or from another source Illum facilis sit q Safety comments Modi voluptatem Imp Blinding and unblinding workspace Autem consequat Ess Blinding and unblinding comments Quibusdam id dicta a Contraception measures workspace Veniam molestiae na Contraception measures comments Ea nisi sint qui ne Discontinuation criteria workspace Vel irure nostrum oc Discontinuation criteria comments Ea Nam possimus exc Other concomitant workspace Perspiciatis conseq Other concomitant comments Quisquam amet ut cu Safety and Monitoring workspace Quia iusto dicta id Safety and Monitoring comments Dolorem qui accusamu Reference Safety Information workspace Voluptatibus molesti Reference Safety Information comments Velit officia ex et Data Safety Monitoring Committee workspace Sapiente corporis in Data Safety Monitoring Committee comments Rem rerum tempore e Definition of the end of the trial workspace Eaque dolor quis qui Definition of the end of the trial comments A quisquam velit ess Biological samples used in the study workspace Vero ad maxime commo Biological samples used in the study comments Aute doloremque repr Data protection workspace Sit eiusmod quo dese Data protection comments Officiis optio eos Recruitment and informed consent procedures workspace Reprehenderit exerc Recruitment and informed consent procedures comment Est asperiores est Benefit/risk assessment workspace Iusto officia ration Comments on the benefit/risk: Facere cupidatat vel Assessor’s overall conclusions workspace Deserunt odio ullam Overall comment/ conclusion on the clinical assessment: Necessitatibus repre 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION A est vero sint re 
 recommendationaccept
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-03-05 16:33:56
 modified2026-03-05 16:34:35
 InternalReview(array)
 0(array)
 id1
 user_id849
 application_id231
 category1
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-06 08:41:56
 modified2026-02-06 08:41:56
 1(array)
 id2
 user_id853
 application_id231
 category1
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation
 notified0
 acceptedaccepted
 conflictNo
 statusUnsubmitted
 created2026-02-06 08:42:02
 modified2026-02-06 09:05:01
 ActiveInspector(empty)
 ManagerReview(array)
 0(array)
 id1
 user_id849
 application_id231
 category1
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-06 08:41:56
 modified2026-02-06 08:41:56
 1(array)
 id2
 user_id853
 application_id231
 category1
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation
 notified0
 acceptedaccepted
 conflictNo
 statusUnsubmitted
 created2026-02-06 08:42:02
 modified2026-02-06 09:05:01
 2(array)
 id3
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summaryTrial category comments Earum ipsum in inven Trial phase comments (if in disagreement with the study phase proposed): Consectetur ipsa s Assessor’s discussion on the clinical development: Eligendi lorem inven Clinical Trial Rationale comments Et repudiandae repel Primary objectives comments Beatae commodi adipi Secondary objectives comments Facere est unde dolo Study population comments Sunt dolore volupta Inclusion criteria comments Beatae dolores enim Exclusion criteria comments Possimus consectetu Vulnerable populations comments Optio tenetur nobis Study plan and design comments Suscipit ullamco qui Study treatment comments Porro incidunt veni Comparator IMP(s) comments Saepe dolorem offici Placebo comments Velit exercitation Auxilliary medicinal product(s) comments Deleniti nostrud har Additional considerations comments Atque a velit volupt Safety comments Ea reiciendis dolore Blinding and unblinding comments Atque corporis corpo Contraception measures comments Iusto velit quaerat Discontinuation criteria comments Nesciunt nulla et l Other concomitant comments Et tenetur fuga Eiu Safety and Monitoring comments Velit duis sint dic Reference Safety Information comments Nihil velit eu id o Data Safety Monitoring Committee comments Quia adipisicing per Definition of the end of the trial comments Et voluptas earum ir Biological samples used in the study comments Pariatur Consequunt Data protection comments Ipsum quis maiores a Recruitment and informed consent procedures comment Minim ex sed ratione Comments on the benefit/risk: Aut quaerat pariatur Overall comment/ conclusion on the clinical assessment: Eaque ut quos illo e 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION Cum voluptate est es
 recommendationdone
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-02-06 09:10:11
 modified2026-02-06 09:31:18
 3(array)
 id4
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summaryTrial category comments Consectetur atque ex Trial phase comments (if in disagreement with the study phase proposed): Nam eu dolor labore Assessor’s discussion on the clinical development: Delectus sunt vero Clinical Trial Rationale comments Exercitationem ut es Primary objectives comments Nesciunt cillum lib Secondary objectives comments Ratione sunt dolorem Study population comments Nesciunt nisi maxim Inclusion criteria comments Elit ipsum optio Exclusion criteria comments Incidunt et aut exp Vulnerable populations comments Veritatis saepe simi Study plan and design comments Saepe quo aut quia n Study treatment comments Alias reiciendis ex Comparator IMP(s) comments Omnis a omnis laboru Placebo comments Officia ipsam dolore Auxilliary medicinal product(s) comments Consequat Dolorum v Additional considerations comments Ipsa sunt cumque e Safety comments Eligendi minus praes Blinding and unblinding comments Corporis quos sunt e Contraception measures comments Nam est aperiam dolo Discontinuation criteria comments Et aut culpa laborum Other concomitant comments Cillum inventore non Safety and Monitoring comments Suscipit corporis fa Reference Safety Information comments Nam provident qui v Data Safety Monitoring Committee comments Qui explicabo Ea no Definition of the end of the trial comments Molestiae sapiente c Biological samples used in the study comments Sunt saepe sit vel Data protection comments Nam eos mollit non e Recruitment and informed consent procedures comment Quos voluptates eaqu Comments on the benefit/risk: Dolore reiciendis do Overall comment/ conclusion on the clinical assessment: Fugit laboriosam u 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION Vitae id velit et oc
 recommendationwow
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-02-06 09:31:50
 modified2026-02-06 09:32:45
 4(array)
 id5
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summaryTrial category comments Exercitation quibusd Trial phase comments (if in disagreement with the study phase proposed): Dolore adipisicing v Assessor’s discussion on the clinical development: Suscipit consequatur Clinical Trial Rationale comments Expedita tempore qu Primary objectives comments Nulla quos alias par Secondary objectives comments Assumenda suscipit d Study population comments Laborum Debitis sin Inclusion criteria comments Eius velit ut veniam Exclusion criteria comments Ex ad voluptas ea se Vulnerable populations comments Tempor soluta qui se Study plan and design comments Possimus non id ut Study treatment comments Cupiditate velit ne Comparator IMP(s) comments Incidunt anim sed i Placebo comments Minima cupiditate vo Auxilliary medicinal product(s) comments Qui voluptatem vel v Additional considerations comments Ullamco distinctio Safety comments Aute occaecat quaera Blinding and unblinding comments Magnam architecto eu Contraception measures comments Lorem assumenda veni Discontinuation criteria comments Quod iure veniam mo Other concomitant comments Quis aut repellendus Safety and Monitoring comments Sit voluptas quis ad Reference Safety Information comments Aperiam nobis mollit Data Safety Monitoring Committee comments Ea eveniet necessit Definition of the end of the trial comments Voluptas ea consequu Biological samples used in the study comments Voluptatem vitae min Data protection comments Officia excepteur qu Recruitment and informed consent procedures comment Quod voluptatum quia Comments on the benefit/risk: Dolores maxime volup Overall comment/ conclusion on the clinical assessment: Dolor dolores id fac 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION Praesentium labore o
 recommendation
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-02-06 09:33:24
 modified2026-02-06 09:36:03
 5(array)
 id6
 user_id3
 application_id231
 category0
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation
 notified0
 acceptedaccepted
 conflictNo
 statusUnsubmitted
 created2026-02-06 10:00:00
 modified2026-02-06 10:00:17
 6(array)
 id7
 user_id790
 application_id231
 category0
 typerequest
 assessment_type(null)
 titlePPB request
 text
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-06 10:00:00
 modified2026-02-06 10:00:00
 7(array)
 id8
 user_id3
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-06 10:00:22
 modified2026-03-05 16:35:34
 8(array)
 id9
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typestatistical
 title(null)
 text(null)
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-09 10:02:05
 modified2026-02-09 10:02:05
 9(array)
 id10
 user_id853
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summary(null)
 recommendation(null)
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-02-10 07:42:53
 modified2026-02-10 07:44:37
 10(array)
 id22
 user_id2
 application_id231
 category0
 typeppb_comment
 assessment_type(null)
 title(null)
 text test
 summary(null)
 recommendation test
 notified0
 accepted(null)
 conflict(null)
 statusUnsubmitted
 created2026-03-05 12:33:51
 modified2026-03-05 12:33:51
 11(array)
 id23
 user_id3
 application_id231
 category0
 typereviewer_comment
 assessment_typeclinical
 title(null)
 text(null)
 summary Trial category workspace Cupidatat dolorem mo Trial category comments Qui qui necessitatib Trial phase workspace Odio accusantium do Trial phase comments (if in disagreement with the study phase proposed): Dicta minus cupidita Therapeutic condition workspace Voluptatibus quos et Brief description of the disease Ipsa sunt qui reru Brief discussion of clinical pharmacokinetic data, efficacy and safety data described in the IB from previous trials /previously investigated indications(s) for the IMP(s). Non-clinical studies may also be discussed for early or FIH clinical trials. Consideration should be given to the justification provided based on the non-clinical data, for the proposed starting dose, dose steps, and maximum exposure Enim eaque molestias Assessor’s discussion on the clinical development: Eligendi voluptatem Consider what is new in this trial, the clinical relevance, and the medical need that the trial aims to address Rerum asperiores ips Clinical Trial Rationale comments Culpa eu vel recusa Consider if there are established primary endpoints for this type of study/indication, do they match the goals, are they validated? Itaque praesentium e Primary objectives comments Ad do ipsum eum non Secondary objectives workspace Voluptatibus facere Secondary objectives comments Et sunt sit ad ut ip Study population workspace Deserunt deserunt mo Study population comments Ad nostrum ad provid Take also into consideration the gender and age allocation of participants, and determine whether a specific group is excluded or underrepresented Qui amet qui quia m Inclusion criteria comments Error deserunt et do Check if a justification is provided in the event that a specific group is excluded or underrepresented Applicable for registered products, consider the contraindications included in the SmPC for the investigational medical product, comparator, and auxiliary medical products Nulla accusamus veli Exclusion criteria comments Dolor enim culpa obc The inclusion of vulnerable population is justifiable only if this information cannot be obtained from non‑vulnerable populations For incapacitated or minor participants, the trial should offer some direct benefit to the tem or to the population that they represent Omnis voluptatem ea Vulnerable populations comments Ea et tempore esse Brief description of the study plan and design, and whenever possible, include a diagram/flow chart Discuss the expected duration of the participants' participation and a description of the sequence and duration of all the clinical trial periods, including the follow up Ab cum quasi ut veri Study plan and design comments Dolorem ipsa eaque Consider the dose(s)/dose steps, dose rationale, route of administration, schedule, treatment duration, and dose modifications Nulla suscipit place Study treatment comments Iste accusamus nostr Comparator IMP(s) workspace Labore eius lorem il Comparator IMP(s) comments Explicabo Cum unde Placebo workspace Totam libero iure do Placebo comments Et quia similique do Auxilliary medicinal product(s) workspace Harum tempora quo er Auxilliary medicinal product(s) comments At nostrud et et atq Additional considerations workspace Qui eaque voluptatem Additional considerations comments Ipsum corporis eum q Brief description of the important safety risks associated with trial treatments identified in any previous clinical trials, and as outlined in the IB or SmPC, or from another source Illum facilis sit q Safety comments Modi voluptatem Imp Blinding and unblinding workspace Autem consequat Ess Blinding and unblinding comments Quibusdam id dicta a Contraception measures workspace Veniam molestiae na Contraception measures comments Ea nisi sint qui ne Discontinuation criteria workspace Vel irure nostrum oc Discontinuation criteria comments Ea Nam possimus exc Other concomitant workspace Perspiciatis conseq Other concomitant comments Quisquam amet ut cu Safety and Monitoring workspace Quia iusto dicta id Safety and Monitoring comments Dolorem qui accusamu Reference Safety Information workspace Voluptatibus molesti Reference Safety Information comments Velit officia ex et Data Safety Monitoring Committee workspace Sapiente corporis in Data Safety Monitoring Committee comments Rem rerum tempore e Definition of the end of the trial workspace Eaque dolor quis qui Definition of the end of the trial comments A quisquam velit ess Biological samples used in the study workspace Vero ad maxime commo Biological samples used in the study comments Aute doloremque repr Data protection workspace Sit eiusmod quo dese Data protection comments Officiis optio eos Recruitment and informed consent procedures workspace Reprehenderit exerc Recruitment and informed consent procedures comment Est asperiores est Benefit/risk assessment workspace Iusto officia ration Comments on the benefit/risk: Facere cupidatat vel Assessor’s overall conclusions workspace Deserunt odio ullam Overall comment/ conclusion on the clinical assessment: Necessitatibus repre 1.5.1 REQUESTS FOR ADDITIONAL INFORMATION A est vero sint re 
 recommendationaccept
 notified0
 accepted(null)
 conflict(null)
 statusSummary
 created2026-03-05 16:33:56
 modified2026-03-05 16:34:35
 Acceptance(empty)
 Amendment(array)
 0(array)
 id72
 application_id231
 trial_status_id(null)
 abstract_of_study
 study_title sample
 laymans_summary
 protocol_no(null)
 version_no
 date_of_protocol(null)
 study_drug
 disease_condition
 product_type(null)
 product_type_biologicals(null)
 product_type_proteins(null)
 product_type_immunologicals(null)
 product_type_vaccines(null)
 product_type_hormones(null)
 product_type_toxoid(null)
 product_type_chemical(null)
 product_type_medical_device(null)
 product_type_chemical_name(null)
 product_type_medical_device_name(null)
 comparator(null)
 comparator_name(null)
 comparator_registered(null)
 comparator_countries(null)
 previous_dates(null)
 coordinating_investigators
 principal_investigators
 pharmacist
 sponsor_details
 gender
 details_of_sites
 placebos
 scopes
 organizations
 types_and_phases
 ecct_not_applicable0
 ecct_ref_number
 email_address(null)
 applicant_covering_letter(null)
 applicant_protocol(null)
 applicant_patient_information(null)
 applicant_investigators_brochure(null)
 applicant_investigators_cv(null)
 applicant_signed_declaration(null)
 applicant_financial_declaration(null)
 applicant_gmp_certificate(null)
 applicant_indemnity_cover(null)
 applicant_opinion_letter(null)
 applicant_approval_letter(null)
 applicant_statement(null)
 applicant_participating_countries(null)
 applicant_addendum(null)
 applicant_fees(null)
 declaration_applicant
 declaration_date1(null)
 declaration_principal_investigator
 declaration_date2(null)
 placebo_present
 study_objectives
 principal_inclusion_criteria
 principal_exclusion_criteria
 primary_end_points
 scope_diagnosis(null)
 scope_prophylaxis(null)
 scope_therapy(null)
 scope_safety(null)
 scope_efficacy(null)
 scope_pharmacokinetic(null)
 scope_pharmacodynamic(null)
 scope_bioequivalence(null)
 scope_dose_response(null)
 scope_pharmacogenetic(null)
 scope_pharmacogenomic(null)
 scope_pharmacoecomomic(null)
 scope_others(null)
 scope_others_specify(null)
 trial_human_pharmacology(null)
 trial_administration_humans(null)
 trial_bioequivalence_study(null)
 trial_other(null)
 trial_other_specify(null)
 trial_therapeutic_exploratory(null)
 trial_therapeutic_confirmatory(null)
 trial_therapeutic_use(null)
 design_controlled
 site_capacity(null)
 staff_numbers
 other_details_explanation
 other_details_regulatory_notapproved
 other_details_regulatory_approved
 other_details_regulatory_rejected
 other_details_regulatory_halted
 estimated_duration
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_state
 location_of_area
 multiple_sites_member_state
 multiple_countries
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committee
 total_enrolment_per_site
 total_participants_worldwide
 population_less_than_18_years
 population_utero
 population_preterm_newborn
 population_newborn
 population_infant_and_toddler
 population_children
 population_adolescent
 population_above_18
 population_adult
 population_elderly
 gender_female(null)
 gender_male(null)
 subjects_healthy
 subjects_patients
 subjects_vulnerable_populations
 subjects_women_child_bearing
 subjects_women_using_contraception
 subjects_pregnant_women
 subjects_nursing_women
 subjects_emergency_situation
 subjects_incapable_consent
 subjects_specify
 subjects_others
 subjects_others_specify
 investigator1_given_name(null)
 investigator1_middle_name(null)
 investigator1_family_name(null)
 investigator1_qualification(null)
 investigator1_professional_address(null)
 organisations_transferred_(null)
 number_participants
 notification
 approval_date(null)
 submitted1
 date_submitted2025-08-05 17:00:04
 modified2025-08-05 17:00:05
 created2025-08-05 16:59:04
 1(array)
 id73
 application_id231
 trial_status_id(null)
 abstract_of_study
 study_title
 laymans_summary
 protocol_no(null)
 version_no
 date_of_protocol(null)
 study_drug
 disease_condition
 product_type(null)
 product_type_biologicals(null)
 product_type_proteins(null)
 product_type_immunologicals(null)
 product_type_vaccines(null)
 product_type_hormones(null)
 product_type_toxoid(null)
 product_type_chemical(null)
 product_type_medical_device(null)
 product_type_chemical_name(null)
 product_type_medical_device_name(null)
 comparator(null)
 comparator_name(null)
 comparator_registered(null)
 comparator_countries(null)
 previous_dates(null)
 coordinating_investigators
 principal_investigatorsName Name Test
 pharmacist
 sponsor_details
 gender
 details_of_sites
 placebos
 scopes
 organizations
 types_and_phases
 ecct_not_applicable0
 ecct_ref_number
 email_address(null)
 applicant_covering_letter(null)
 applicant_protocol(null)
 applicant_patient_information(null)
 applicant_investigators_brochure(null)
 applicant_investigators_cv(null)
 applicant_signed_declaration(null)
 applicant_financial_declaration(null)
 applicant_gmp_certificate(null)
 applicant_indemnity_cover(null)
 applicant_opinion_letter(null)
 applicant_approval_letter(null)
 applicant_statement(null)
 applicant_participating_countries(null)
 applicant_addendum(null)
 applicant_fees(null)
 declaration_applicant
 declaration_date1(null)
 declaration_principal_investigator
 declaration_date2(null)
 placebo_present
 study_objectives
 principal_inclusion_criteria
 principal_exclusion_criteria
 primary_end_points
 scope_diagnosis(null)
 scope_prophylaxis(null)
 scope_therapy(null)
 scope_safety(null)
 scope_efficacy(null)
 scope_pharmacokinetic(null)
 scope_pharmacodynamic(null)
 scope_bioequivalence(null)
 scope_dose_response(null)
 scope_pharmacogenetic(null)
 scope_pharmacogenomic(null)
 scope_pharmacoecomomic(null)
 scope_others(null)
 scope_others_specify(null)
 trial_human_pharmacology(null)
 trial_administration_humans(null)
 trial_bioequivalence_study(null)
 trial_other(null)
 trial_other_specify(null)
 trial_therapeutic_exploratory(null)
 trial_therapeutic_confirmatory(null)
 trial_therapeutic_use(null)
 design_controlled
 site_capacity(null)
 staff_numbers
 other_details_explanation
 other_details_regulatory_notapproved
 other_details_regulatory_approved
 other_details_regulatory_rejected
 other_details_regulatory_halted
 estimated_duration
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_state
 location_of_area
 multiple_sites_member_state
 multiple_countries
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committee
 total_enrolment_per_site
 total_participants_worldwide
 population_less_than_18_years
 population_utero
 population_preterm_newborn
 population_newborn
 population_infant_and_toddler
 population_children
 population_adolescent
 population_above_18
 population_adult
 population_elderly
 gender_female(null)
 gender_male(null)
 subjects_healthy
 subjects_patients
 subjects_vulnerable_populations
 subjects_women_child_bearing
 subjects_women_using_contraception
 subjects_pregnant_women
 subjects_nursing_women
 subjects_emergency_situation
 subjects_incapable_consent
 subjects_specify
 subjects_others
 subjects_others_specify
 investigator1_given_name(null)
 investigator1_middle_name(null)
 investigator1_family_name(null)
 investigator1_qualification(null)
 investigator1_professional_address(null)
 organisations_transferred_(null)
 number_participants
 notification
 approval_date(null)
 submitted1
 date_submitted2025-08-08 09:45:01
 modified2025-08-08 09:45:01
 created2025-08-08 09:43:31
 2(array)
 id74
 application_id231
 trial_status_id(null)
 abstract_of_study
 study_title
 laymans_summary
 protocol_no(null)
 version_no
 date_of_protocol(null)
 study_drug
 disease_condition
 product_type(null)
 product_type_biologicals(null)
 product_type_proteins(null)
 product_type_immunologicals(null)
 product_type_vaccines(null)
 product_type_hormones(null)
 product_type_toxoid(null)
 product_type_chemical(null)
 product_type_medical_device(null)
 product_type_chemical_name(null)
 product_type_medical_device_name(null)
 comparator(null)
 comparator_name(null)
 comparator_registered(null)
 comparator_countries(null)
 previous_dates(null)
 coordinating_investigators
 principal_investigators
 pharmacist
 sponsor_details
 gender
 details_of_sites
 placebos
 scopes
 organizations
 types_and_phases
 ecct_not_applicable0
 ecct_ref_number
 email_address(null)
 applicant_covering_letter(null)
 applicant_protocol(null)
 applicant_patient_information(null)
 applicant_investigators_brochure(null)
 applicant_investigators_cv(null)
 applicant_signed_declaration(null)
 applicant_financial_declaration(null)
 applicant_gmp_certificate(null)
 applicant_indemnity_cover(null)
 applicant_opinion_letter(null)
 applicant_approval_letter(null)
 applicant_statement(null)
 applicant_participating_countries(null)
 applicant_addendum(null)
 applicant_fees(null)
 declaration_applicant
 declaration_date1(null)
 declaration_principal_investigator
 declaration_date2(null)
 placebo_present
 study_objectivesonly option
 principal_inclusion_criteria
 principal_exclusion_criteria
 primary_end_points
 scope_diagnosis(null)
 scope_prophylaxis(null)
 scope_therapy(null)
 scope_safety(null)
 scope_efficacy(null)
 scope_pharmacokinetic(null)
 scope_pharmacodynamic(null)
 scope_bioequivalence(null)
 scope_dose_response(null)
 scope_pharmacogenetic(null)
 scope_pharmacogenomic(null)
 scope_pharmacoecomomic(null)
 scope_others(null)
 scope_others_specify(null)
 trial_human_pharmacology(null)
 trial_administration_humans(null)
 trial_bioequivalence_study(null)
 trial_other(null)
 trial_other_specify(null)
 trial_therapeutic_exploratory(null)
 trial_therapeutic_confirmatory(null)
 trial_therapeutic_use(null)
 design_controlled
 site_capacity(null)
 staff_numbers
 other_details_explanation
 other_details_regulatory_notapproved
 other_details_regulatory_approved
 other_details_regulatory_rejected
 other_details_regulatory_halted
 estimated_duration
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_state
 location_of_area
 multiple_sites_member_state
 multiple_countries
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committee
 total_enrolment_per_site
 total_participants_worldwide
 population_less_than_18_years
 population_utero
 population_preterm_newborn
 population_newborn
 population_infant_and_toddler
 population_children
 population_adolescent
 population_above_18
 population_adult
 population_elderly
 gender_female(null)
 gender_male(null)
 subjects_healthy
 subjects_patients
 subjects_vulnerable_populations
 subjects_women_child_bearing
 subjects_women_using_contraception
 subjects_pregnant_women
 subjects_nursing_women
 subjects_emergency_situation
 subjects_incapable_consent
 subjects_specify
 subjects_others
 subjects_others_specify
 investigator1_given_name(null)
 investigator1_middle_name(null)
 investigator1_family_name(null)
 investigator1_qualification(null)
 investigator1_professional_address(null)
 organisations_transferred_(null)
 number_participants
 notification
 approval_date(null)
 submitted1
 date_submitted2025-08-08 10:08:27
 modified2025-08-08 10:08:27
 created2025-08-08 10:07:02
 3(array)
 id75
 application_id231
 trial_status_id(null)
 abstract_of_study
 study_title
 laymans_summary
 protocol_no(null)
 version_no
 date_of_protocol(null)
 study_drug
 disease_condition
 product_type(null)
 product_type_biologicals(null)
 product_type_proteins(null)
 product_type_immunologicals(null)
 product_type_vaccines(null)
 product_type_hormones(null)
 product_type_toxoid(null)
 product_type_chemical(null)
 product_type_medical_device(null)
 product_type_chemical_name(null)
 product_type_medical_device_name(null)
 comparator(null)
 comparator_name(null)
 comparator_registered(null)
 comparator_countries(null)
 previous_dates(null)
 coordinating_investigators
 principal_investigators
 pharmacist
 sponsor_details
 gender
 details_of_sites
 placebos
 scopes
 organizations
 types_and_phases
 ecct_not_applicable0
 ecct_ref_number
 email_address(null)
 applicant_covering_letter(null)
 applicant_protocol(null)
 applicant_patient_information(null)
 applicant_investigators_brochure(null)
 applicant_investigators_cv(null)
 applicant_signed_declaration(null)
 applicant_financial_declaration(null)
 applicant_gmp_certificate(null)
 applicant_indemnity_cover(null)
 applicant_opinion_letter(null)
 applicant_approval_letter(null)
 applicant_statement(null)
 applicant_participating_countries(null)
 applicant_addendum(null)
 applicant_fees(null)
 declaration_applicant
 declaration_date1(null)
 declaration_principal_investigator
 declaration_date2(null)
 placebo_present
 study_objectives
 principal_inclusion_criteria
 principal_exclusion_criteria
 primary_end_points
 scope_diagnosis(null)
 scope_prophylaxis(null)
 scope_therapy(null)
 scope_safety(null)
 scope_efficacy(null)
 scope_pharmacokinetic(null)
 scope_pharmacodynamic(null)
 scope_bioequivalence(null)
 scope_dose_response(null)
 scope_pharmacogenetic(null)
 scope_pharmacogenomic(null)
 scope_pharmacoecomomic(null)
 scope_others(null)
 scope_others_specify(null)
 trial_human_pharmacology(null)
 trial_administration_humans(null)
 trial_bioequivalence_study(null)
 trial_other(null)
 trial_other_specify(null)
 trial_therapeutic_exploratory(null)
 trial_therapeutic_confirmatory(null)
 trial_therapeutic_use(null)
 design_controlled
 site_capacity(null)
 staff_numbers
 other_details_explanation
 other_details_regulatory_notapproved
 other_details_regulatory_approved
 other_details_regulatory_rejected
 other_details_regulatory_halted
 estimated_duration
 design_controlled_randomised
 design_controlled_open
 design_controlled_single_blind
 design_controlled_double_blind
 design_controlled_parallel_group
 design_controlled_cross_over
 design_controlled_other
 design_controlled_specify
 design_controlled_comparator
 design_controlled_other_medicinal
 design_controlled_placebo
 design_controlled_medicinal_other
 design_controlled_medicinal_specify
 single_site_member_state
 location_of_area
 multiple_sites_member_state
 multiple_countries
 multiple_member_states
 number_of_sites
 multi_country_list
 data_monitoring_committee
 total_enrolment_per_site
 total_participants_worldwide
 population_less_than_18_years
 population_utero
 population_preterm_newborn
 population_newborn
 population_infant_and_toddler
 population_children
 population_adolescent
 population_above_18
 population_adult
 population_elderly
 gender_female(null)
 gender_male(null)
 subjects_healthy
 subjects_patients
 subjects_vulnerable_populations
 subjects_women_child_bearing
 subjects_women_using_contraception
 subjects_pregnant_women
 subjects_nursing_women
 subjects_emergency_situation
 subjects_incapable_consent
 subjects_specify
 subjects_others
 subjects_others_specify
 investigator1_given_name(null)
 investigator1_middle_name(null)
 investigator1_family_name(null)
 investigator1_qualification(null)
 investigator1_professional_address(null)
 organisations_transferred_(null)
 number_participants
 notification
 approval_date(null)
 submitted1
 date_submitted2026-02-17 10:47:35
 modified2026-02-17 10:47:35
 created2026-02-04 08:34:53
 InvestigatorContact(array)
 0(array)
 id146
 application_id231
 given_nameKiprotich
 middle_nameKeter
 family_nameJapheth
 qualificationNurse
 professional_addresssample
 telephone0724743789
 emailitsjkiprotich@gmail.com
 investigator_roleprincipal
 created2025-03-27 12:53:06
 modified2025-07-11 17:33:23
 ApplicationStage(array)
 0(array)
 id315
 application_id231
 stageScreening
 start_date2025-07-11
 statusComplete
 commentManager first comment
 end_date2025-09-17
 created2025-07-11 17:33:23
 modified2025-07-11 17:33:23
 1(array)
 id316
 application_id231
 stageScreeningSubmission
 start_date2025-09-17
 statusComplete
 commentManager assign reviewer
 end_date2025-09-17
 created2025-09-17 14:08:07
 modified2025-09-17 14:08:07
 2(array)
 id317
 application_id231
 stageAssign
 start_date2025-09-17
 statusComplete
 commentReviewer accept
 end_date2025-09-17
 created2025-09-17 14:08:44
 modified2025-09-17 14:08:44
 3(array)
 id318
 application_id231
 stageReview
 start_date2025-09-17
 statusComplete
 commentManager review comment
 end_date2025-09-30
 created2025-09-17 14:12:46
 modified2025-09-17 14:12:46
 4(array)
 id319
 application_id231
 stageReviewSubmission
 start_date2025-09-30
 statusComplete
 commentApplicant review response
 end_date2026-03-05
 created2025-09-30 16:38:08
 modified2025-09-30 16:38:08
 5(array)
 id320
 application_id231
 stageFinalDecision
 start_date2025-09-30
 statusComplete
 commentManager final decision
 end_date2025-09-30
 created2025-09-30 16:40:10
 modified2025-09-30 16:40:10
 6(array)
 id321
 application_id231
 stageAnnualApproval
 start_date2025-09-30
 statusCurrent
 commentManager letter approve
 end_date2026-09-30
 created2025-09-30 16:40:10
 modified2025-09-30 16:40:10
 Pharmacist(array)
 0(array)
 id56
 application_id231
 reg_nosampe3232
 given_namesample sample
 premise_namesample
 qualificationsample
 professional_addresssample
 valid_year2023
 mobile
 telephone0700543292
 emailsample@gmail.com
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 EthicalCommittee(array)
 0(array)
 id57
 application_id231
 ethical_committeeInternational Livestock Research Institute (ILRI)
 submission_date11-07-2025
 erc_number43we23
 initial_approval04-07-2025
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 AnnualLetter(array)
 0(array)
 id91
 application_id231
 approval_noPPB/ECCT/25/07/01/2025(62)
 type0
 content<h3 style="text-align: center;"> <img height="86" src="https://lh7-us.googleusercontent.com/eOWVvo3AHW74GguHveDaqdgy3YwNZqOqOO0QtscRoV4hJfcvt8Q6v4oLN3beVNvClvoD1ncu1RhB5D4iuAY-5R9h1aD2lEGqUorBVcQ0azfxsdvIz-WhbF3rA9-VQomtusnP2bNZTuYLFTC6vQ46nQ" style="background-color: transparent; color: rgb(0, 0, 0); font-family: "Bookman Old Style", serif; font-size: 11pt; white-space-collapse: preserve; margin-left: 0px; margin-top: 0px;" width="116" /></h3> MINISTRY OF HEALTH PHARMACY AND POISONS BOARD <table style="width: 100%; border:0px"> <tbody> <tr> <td style="width: 33.33%; border:0px"> <div id="left-editor"> Telegram: "MINHEALTH", Nairobi Cell phone: 0709 770 100 Email: info@pharmacyboardkenya.org Website: web.pharmacyboardkenya.org </div> </td> <td style="width: 33.33%;border:0px"> </td> <td style="width: 33.33%;border:0px"> <div id="right-editor"> Pharmacy and Poisons Board House Along Lenana Road P.O. Box 27663-00506 NAIROBI </div> </td> </tr> </tbody> </table> <address> </address> <address> When replying please quote</address> Ref. No. PPB/ECCT/25/07/01/2025(62) 30th September 2025 Kiprotich Keter Japheth, Principal Investigator ECCT/25/07/01, sample, Dear Sir/Madam, Re: ECCT/25/07/01 : Initial Approval; Test :short_title. Reference is made to the above study. We acknowledge receipt of the following documents; <div style="margin-left: 15px;"> 1. Cover Letter (Should list all the submitted documents, their version numbers and dates) <a href="http://45.79.161.190:8080/attachments/download/1854">24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp</a> dated 1st January 1970 Version 2. A signed statement by the applicant indicating that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading. <a href="http://45.79.161.190:8080/attachments/download/1855">24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp</a> dated 5th March 2025 Version <a href="http://45.79.161.190:8080/attachments/download/2273">screenshot_5.png</a> dated 11th July 2025 Version 1 3. Payment of fees <a href="http://45.79.161.190:8080/attachments/download/1856">24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp</a> dated 20th March 2025 Version <a href="http://45.79.161.190:8080/attachments/download/2272">screenshot_4.png</a> dated 11th July 2025 Version 1 4. The Study Protocol <a href="http://45.79.161.190:8080/attachments/download/2224">screenshot_from_2025_04_10_06_44_36_5.png</a> dated 1st January 1970 Version 5. Patient Information leaflet and Informed consent form <a href="http://45.79.161.190:8080/attachments/download/2225">screenshot_from_2025_04_10_06_44_36_6.png</a> dated 1st January 1970 Version 6. Registration of the study at Pan African Clinical Trials Registry https://pactr.samrc.ac.za <a href="http://45.79.161.190:8080/attachments/download/2226">screenshot_from_2025_04_10_06_44_36_7.png</a> dated 10th April 2025 Version 7. Copy of favorable opinion letter from the local Ethics Review Committee (ERC). <a href="http://45.79.161.190:8080/attachments/download/2274">screenshot_6.png</a> dated 11th July 2025 Version 1 8. Clinical Trials Insurance cover for study participants <a href="http://45.79.161.190:8080/attachments/download/2275">screenshot_7.png</a> dated 11th July 2025 Version 1 9. Signed Declaration by Sponsor or Principal investigator that the study will be carried out according to the protocol and applicable laws, regulations and GCP requirements. <a href="http://45.79.161.190:8080/attachments/export/1732"> click here </a> <a href="http://45.79.161.190:8080/attachments/download/2276">screenshot_8.png</a> dated 11th July 2025 Version 1 10. Financial declaration by Sponsor and/or PI <a href="http://45.79.161.190:8080/attachments/export/1736">click here</a> <a href="http://45.79.161.190:8080/attachments/download/2277">screenshot_9.png</a> dated 11th July 2025 Version 1 11. Signed investigator(s) CV(s) including that of study Pharmacist (NB: The CV should include the current workload of the Principal Investigator ) <a href="http://45.79.161.190:8080/attachments/download/2278">screenshot_10.png</a> dated 11th July 2025 Version 1 12. GMP certificate of the investigational product from the site of manufacture <a href="http://45.79.161.190:8080/attachments/download/2279">screenshot_11.png</a> dated 11th July 2025 Version 1 13. Investigators Brochure/Package inserts <a href="http://45.79.161.190:8080/attachments/download/2280">screenshot_12.png</a> dated 11th July 2025 Version 3</div> After review of the documents, the Pharmacy and Poisons Board Expert Committee on Clinical Trials notes the following: :reviewer_summary_comments The Pharmacy and Poisons Board Expert Committee on Clinical Trials grants approval to the study: Test ECCT/25/07/01. This approval is valid for one year and in case the study extends beyond one year from the date of this letter, you are required to seek approval before proceeding with the study. The expiry date is 30th September 2026 <ol> <li> You should ensure compliance with Kenya Legal, regulatory and GCP requirements</li> <li> All safety reports should be submitted to ECCT as per the current PPB clinical trials guidelines</li> <li> It is your responsibility to inform the PPB of any changes to the protocol, research design and procedures that could introduce new or more than minimum risk to human subjects</li> <li> You are also reminded that upon conclusion of the study, you shall be required to submit the executive summary report of the study within 30 days while a copy of the clinical study report in ICH E3 format should be submitted to us within 180 days of the study closure.</li> </ol> <div> Yours Sincerely, </div> :signature :approver For Chief Executive Officer 
 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
 approvermanager
 approval_date30-09-2025
 expiry_date30-09-2026
 statusapproved
 deleted0
 deleted_date(null)
 created2025-09-30 16:40:10
 modified2025-09-30 16:41:03
 1(array)
 id92
 application_id231
 approval_noAPL/2/2025-ECCT/25/07/01
 type0
 content<h3 style="text-align: center;"> <img height="86" src="https://lh7-us.googleusercontent.com/eOWVvo3AHW74GguHveDaqdgy3YwNZqOqOO0QtscRoV4hJfcvt8Q6v4oLN3beVNvClvoD1ncu1RhB5D4iuAY-5R9h1aD2lEGqUorBVcQ0azfxsdvIz-WhbF3rA9-VQomtusnP2bNZTuYLFTC6vQ46nQ" style="background-color: transparent; color: rgb(0, 0, 0); font-family: "Bookman Old Style", serif; font-size: 11pt; white-space-collapse: preserve; margin-left: 0px; margin-top: 0px;" width="116" /></h3> MINISTRY OF HEALTH PHARMACY AND POISONS BOARD <table style="width: 100%; border:0px"> <tbody> <tr> <td style="width: 33.33%; border:0px"> <div id="left-editor"> Telegram: "MINHEALTH", Nairobi Cell phone: 0709 770 100 Email: info@pharmacyboardkenya.org Website: web.pharmacyboardkenya.org </div> </td> <td style="width: 33.33%;border:0px"> </td> <td style="width: 33.33%;border:0px"> <div id="right-editor"> Pharmacy and Poisons Board House Along Lenana Road P.O. Box 27663-00506 NAIROBI </div> </td> </tr> </tbody> </table> <address> </address> <address> When replying please quote</address> Ref. No. APL/2/2025-ECCT/25/07/01 30 Sep 2025 Kiprotich Keter Japheth, Principal Investigator ECCT/25/07/01, sample, Dear Sir/Madam, Re: ECCT/25/07/01 : Initial Approval; Test :short_title. Reference is made to the above study. We acknowledge receipt of the following documents; <div style="margin-left: 15px;"> 1. Cover Letter (Should list all the submitted documents, their version numbers and dates) <a href="/attachments/download/1854">24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp</a> dated 1st January 1970 Version 2. A signed statement by the applicant indicating that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading. <a href="/attachments/download/1855">24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp</a> dated 5th March 2025 Version <a href="/attachments/download/2273">screenshot_5.png</a> dated 11th July 2025 Version 1 3. Payment of fees <a href="/attachments/download/1856">24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp</a> dated 20th March 2025 Version <a href="/attachments/download/2272">screenshot_4.png</a> dated 11th July 2025 Version 1 4. The Study Protocol <a href="/attachments/download/2224">screenshot_from_2025_04_10_06_44_36_5.png</a> dated 1st January 1970 Version 5. Patient Information leaflet and Informed consent form <a href="/attachments/download/2225">screenshot_from_2025_04_10_06_44_36_6.png</a> dated 1st January 1970 Version 6. Registration of the study at Pan African Clinical Trials Registry https://pactr.samrc.ac.za <a href="/attachments/download/2226">screenshot_from_2025_04_10_06_44_36_7.png</a> dated 10th April 2025 Version 7. Copy of favorable opinion letter from the local Ethics Review Committee (ERC). <a href="/attachments/download/2274">screenshot_6.png</a> dated 11th July 2025 Version 1 8. Clinical Trials Insurance cover for study participants <a href="/attachments/download/2275">screenshot_7.png</a> dated 11th July 2025 Version 1 9. Signed Declaration by Sponsor or Principal investigator that the study will be carried out according to the protocol and applicable laws, regulations and GCP requirements. <a href="http://45.79.161.190:8080/attachments/export/1732"> click here </a> <a href="/attachments/download/2276">screenshot_8.png</a> dated 11th July 2025 Version 1 10. Financial declaration by Sponsor and/or PI <a href="http://45.79.161.190:8080/attachments/export/1736">click here</a> <a href="/attachments/download/2277">screenshot_9.png</a> dated 11th July 2025 Version 1 11. Signed investigator(s) CV(s) including that of study Pharmacist (NB: The CV should include the current workload of the Principal Investigator ) <a href="/attachments/download/2278">screenshot_10.png</a> dated 11th July 2025 Version 1 12. GMP certificate of the investigational product from the site of manufacture <a href="/attachments/download/2279">screenshot_11.png</a> dated 11th July 2025 Version 1 13. Investigators Brochure/Package inserts <a href="/attachments/download/2280">screenshot_12.png</a> dated 11th July 2025 Version 3 </div> After review of the documents, the Pharmacy and Poisons Board Expert Committee on Clinical Trials notes the following: :reviewer_summary_comments The Pharmacy and Poisons Board Expert Committee on Clinical Trials grants approval to the study: Test ECCT/25/07/01. This approval is valid for one year and in case the study extends beyond one year from the date of this letter, you are required to seek approval before proceeding with the study. The expiry date is 30th September 2026 <ol> <li> You should ensure compliance with Kenya Legal, regulatory and GCP requirements</li> <li> All safety reports should be submitted to ECCT as per the current PPB clinical trials guidelines</li> <li> It is your responsibility to inform the PPB of any changes to the protocol, research design and procedures that could introduce new or more than minimum risk to human subjects</li> <li> You are also reminded that upon conclusion of the study, you shall be required to submit the executive summary report of the study within 30 days while a copy of the clinical study report in ICH E3 format should be submitted to us within 180 days of the study closure.</li> </ol> <div> Yours Sincerely, </div> :signature :approver For Chief Executive Officer 
 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
 approvermanager
 approval_date03-02-2026
 expiry_date03-02-2027
 statussubmitted
 deleted0
 deleted_date(null)
 created2026-02-03 10:35:33
 modified2026-02-03 10:35:33
 2(array)
 id93
 application_id231
 approval_noAPL/3/2025-ECCT/25/07/01
 type0
 content<h3 style="text-align: center;"> <img height="86" src="https://lh7-us.googleusercontent.com/eOWVvo3AHW74GguHveDaqdgy3YwNZqOqOO0QtscRoV4hJfcvt8Q6v4oLN3beVNvClvoD1ncu1RhB5D4iuAY-5R9h1aD2lEGqUorBVcQ0azfxsdvIz-WhbF3rA9-VQomtusnP2bNZTuYLFTC6vQ46nQ" style="background-color: transparent; color: rgb(0, 0, 0); font-family: "Bookman Old Style", serif; font-size: 11pt; white-space-collapse: preserve; margin-left: 0px; margin-top: 0px;" width="116" /></h3> MINISTRY OF HEALTH PHARMACY AND POISONS BOARD <table style="width: 100%; border:0px"> <tbody> <tr> <td style="width: 33.33%; border:0px"> <div id="left-editor"> Telegram: "MINHEALTH", Nairobi Cell phone: 0709 770 100 Email: info@pharmacyboardkenya.org Website: web.pharmacyboardkenya.org </div> </td> <td style="width: 33.33%;border:0px"> </td> <td style="width: 33.33%;border:0px"> <div id="right-editor"> Pharmacy and Poisons Board House Along Lenana Road P.O. Box 27663-00506 NAIROBI </div> </td> </tr> </tbody> </table> <address> </address> <address> When replying please quote</address> Ref. No. APL/3/2025-ECCT/25/07/01 30 Sep 2025 Kiprotich Keter Japheth, Principal Investigator ECCT/25/07/01, sample, Dear Sir/Madam, Re: ECCT/25/07/01 : Annual Approval; Test :short_title. Reference is made to the above study. We acknowledge receipt of the following documents; <div style="margin-left: 15px;"> 1. Cover Letter (Should list all the submitted documents, their version numbers and dates) <a href="/attachments/download/2288">web_app_backend_development_practical_1.pdf</a> dated 22nd January 2026 Version 1 </div> After review of the documents, the Pharmacy and Poisons Board Expert Committee on Clinical Trials notes the following: :reviewer_summary_comments The Pharmacy and Poisons Board Expert Committee on Clinical Trials grants approval to the study: Test ECCT/25/07/01. This approval is valid for one year and in case the study extends beyond one year from the date of this letter, you are required to seek approval before proceeding with the study. The expiry date is 3rd February 2027 <ol> <li> You should ensure compliance with Kenya Legal, regulatory and GCP requirements</li> <li> All safety reports should be submitted to ECCT as per the current PPB clinical trials guidelines</li> <li> It is your responsibility to inform the PPB of any changes to the protocol, research design and procedures that could introduce new or more than minimum risk to human subjects</li> <li> You are also reminded that upon conclusion of the study, you shall be required to submit the executive summary report of the study within 30 days while a copy of the clinical study report in ICH E3 format should be submitted to us within 180 days of the study closure</li> </ol> <div> Yours Sincerely, </div> :signature :approver For Chief Executive Officer 
 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
 approvermanager
 approval_date03-02-2026
 expiry_date03-02-2027
 statussubmitted
 deleted0
 deleted_date(null)
 created2026-02-03 10:35:49
 modified2026-02-03 10:35:49
 3(array)
 id94
 application_id231
 approval_noAPL/4/2025-ECCT/25/07/01
 type0
 content<h3 style="text-align: center;"> <img height="86" src="https://lh7-us.googleusercontent.com/eOWVvo3AHW74GguHveDaqdgy3YwNZqOqOO0QtscRoV4hJfcvt8Q6v4oLN3beVNvClvoD1ncu1RhB5D4iuAY-5R9h1aD2lEGqUorBVcQ0azfxsdvIz-WhbF3rA9-VQomtusnP2bNZTuYLFTC6vQ46nQ" style="background-color: transparent; color: rgb(0, 0, 0); font-family: "Bookman Old Style", serif; font-size: 11pt; white-space-collapse: preserve; margin-left: 0px; margin-top: 0px;" width="116" /></h3> MINISTRY OF HEALTH PHARMACY AND POISONS BOARD <table style="width: 100%; border:0px"> <tbody> <tr> <td style="width: 33.33%; border:0px"> <div id="left-editor"> Telegram: "MINHEALTH", Nairobi Cell phone: 0709 770 100 Email: info@pharmacyboardkenya.org Website: web.pharmacyboardkenya.org </div> </td> <td style="width: 33.33%;border:0px"> </td> <td style="width: 33.33%;border:0px"> <div id="right-editor"> Pharmacy and Poisons Board House Along Lenana Road P.O. Box 27663-00506 NAIROBI </div> </td> </tr> </tbody> </table> <address> </address> <address> When replying please quote</address> Ref. No. APL/4/2025-ECCT/25/07/01 30 Sep 2025 Kiprotich Keter Japheth, Principal Investigator ECCT/25/07/01, sample, Dear Sir/Madam, Re: ECCT/25/07/01 : Initial Approval; Test :short_title. Reference is made to the above study. We acknowledge receipt of the following documents; <div style="margin-left: 15px;"> 1. Cover Letter (Should list all the submitted documents, their version numbers and dates) <a href="/attachments/download/1854">24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp</a> dated 1st January 1970 Version 2. A signed statement by the applicant indicating that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading. <a href="/attachments/download/1855">24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp</a> dated 5th March 2025 Version <a href="/attachments/download/2273">screenshot_5.png</a> dated 11th July 2025 Version 1 3. Payment of fees <a href="/attachments/download/1856">24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp</a> dated 20th March 2025 Version <a href="/attachments/download/2272">screenshot_4.png</a> dated 11th July 2025 Version 1 4. The Study Protocol <a href="/attachments/download/2224">screenshot_from_2025_04_10_06_44_36_5.png</a> dated 1st January 1970 Version 5. Patient Information leaflet and Informed consent form <a href="/attachments/download/2225">screenshot_from_2025_04_10_06_44_36_6.png</a> dated 1st January 1970 Version 6. Registration of the study at Pan African Clinical Trials Registry https://pactr.samrc.ac.za <a href="/attachments/download/2226">screenshot_from_2025_04_10_06_44_36_7.png</a> dated 10th April 2025 Version 7. Copy of favorable opinion letter from the local Ethics Review Committee (ERC). <a href="/attachments/download/2274">screenshot_6.png</a> dated 11th July 2025 Version 1 8. Clinical Trials Insurance cover for study participants <a href="/attachments/download/2275">screenshot_7.png</a> dated 11th July 2025 Version 1 9. Signed Declaration by Sponsor or Principal investigator that the study will be carried out according to the protocol and applicable laws, regulations and GCP requirements. <a href="http://45.79.161.190:8080/attachments/export/1732"> click here </a> <a href="/attachments/download/2276">screenshot_8.png</a> dated 11th July 2025 Version 1 10. Financial declaration by Sponsor and/or PI <a href="http://45.79.161.190:8080/attachments/export/1736">click here</a> <a href="/attachments/download/2277">screenshot_9.png</a> dated 11th July 2025 Version 1 11. Signed investigator(s) CV(s) including that of study Pharmacist (NB: The CV should include the current workload of the Principal Investigator ) <a href="/attachments/download/2278">screenshot_10.png</a> dated 11th July 2025 Version 1 12. GMP certificate of the investigational product from the site of manufacture <a href="/attachments/download/2279">screenshot_11.png</a> dated 11th July 2025 Version 1 13. Investigators Brochure/Package inserts <a href="/attachments/download/2280">screenshot_12.png</a> dated 11th July 2025 Version 3 </div> After review of the documents, the Pharmacy and Poisons Board Expert Committee on Clinical Trials notes the following: :reviewer_summary_comments The Pharmacy and Poisons Board Expert Committee on Clinical Trials grants approval to the study: Test ECCT/25/07/01. This approval is valid for one year and in case the study extends beyond one year from the date of this letter, you are required to seek approval before proceeding with the study. The expiry date is 30th September 2026 <ol> <li> You should ensure compliance with Kenya Legal, regulatory and GCP requirements</li> <li> All safety reports should be submitted to ECCT as per the current PPB clinical trials guidelines</li> <li> It is your responsibility to inform the PPB of any changes to the protocol, research design and procedures that could introduce new or more than minimum risk to human subjects</li> <li> You are also reminded that upon conclusion of the study, you shall be required to submit the executive summary report of the study within 30 days while a copy of the clinical study report in ICH E3 format should be submitted to us within 180 days of the study closure.</li> </ol> <div> Yours Sincerely, </div> :signature :approver For Chief Executive Officer 
 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
 approvermanager
 approval_date03-02-2026
 expiry_date03-02-2027
 statussubmitted
 deleted0
 deleted_date(null)
 created2026-02-03 10:36:01
 modified2026-02-03 10:36:01
 4(array)
 id95
 application_id231
 approval_noAPL/5/2025-ECCT/25/07/01
 type0
 content<h3 style="text-align: center;"> <img height="86" src="https://lh7-us.googleusercontent.com/eOWVvo3AHW74GguHveDaqdgy3YwNZqOqOO0QtscRoV4hJfcvt8Q6v4oLN3beVNvClvoD1ncu1RhB5D4iuAY-5R9h1aD2lEGqUorBVcQ0azfxsdvIz-WhbF3rA9-VQomtusnP2bNZTuYLFTC6vQ46nQ" style="background-color: transparent; color: rgb(0, 0, 0); font-family: "Bookman Old Style", serif; font-size: 11pt; white-space-collapse: preserve; margin-left: 0px; margin-top: 0px;" width="116" /></h3> MINISTRY OF HEALTH PHARMACY AND POISONS BOARD <table style="width: 100%; border:0px"> <tbody> <tr> <td style="width: 33.33%; border:0px"> <div id="left-editor"> Telegram: "MINHEALTH", Nairobi Cell phone: 0709 770 100 Email: info@pharmacyboardkenya.org Website: web.pharmacyboardkenya.org </div> </td> <td style="width: 33.33%;border:0px"> </td> <td style="width: 33.33%;border:0px"> <div id="right-editor"> Pharmacy and Poisons Board House Along Lenana Road P.O. Box 27663-00506 NAIROBI </div> </td> </tr> </tbody> </table> <address> </address> <address> When replying please quote</address> Ref. No. APL/5/2025-ECCT/25/07/01 30 Sep 2025 Kiprotich Keter Japheth, Principal Investigator ECCT/25/07/01, sample, Dear Sir/Madam, Re: ECCT/25/07/01 : Initial Approval; Test :short_title. Reference is made to the above study. We acknowledge receipt of the following documents; <div style="margin-left: 15px;"> 1. Cover Letter (Should list all the submitted documents, their version numbers and dates) <a href="/attachments/download/1854">24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp</a> dated 1st January 1970 Version 2. A signed statement by the applicant indicating that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading. <a href="/attachments/download/1855">24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp</a> dated 5th March 2025 Version <a href="/attachments/download/2273">screenshot_5.png</a> dated 11th July 2025 Version 1 3. Payment of fees <a href="/attachments/download/1856">24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp</a> dated 20th March 2025 Version <a href="/attachments/download/2272">screenshot_4.png</a> dated 11th July 2025 Version 1 4. The Study Protocol <a href="/attachments/download/2224">screenshot_from_2025_04_10_06_44_36_5.png</a> dated 1st January 1970 Version 5. Patient Information leaflet and Informed consent form <a href="/attachments/download/2225">screenshot_from_2025_04_10_06_44_36_6.png</a> dated 1st January 1970 Version 6. Registration of the study at Pan African Clinical Trials Registry https://pactr.samrc.ac.za <a href="/attachments/download/2226">screenshot_from_2025_04_10_06_44_36_7.png</a> dated 10th April 2025 Version 7. Copy of favorable opinion letter from the local Ethics Review Committee (ERC). <a href="/attachments/download/2274">screenshot_6.png</a> dated 11th July 2025 Version 1 8. Clinical Trials Insurance cover for study participants <a href="/attachments/download/2275">screenshot_7.png</a> dated 11th July 2025 Version 1 9. Signed Declaration by Sponsor or Principal investigator that the study will be carried out according to the protocol and applicable laws, regulations and GCP requirements. <a href="http://45.79.161.190:8080/attachments/export/1732"> click here </a> <a href="/attachments/download/2276">screenshot_8.png</a> dated 11th July 2025 Version 1 10. Financial declaration by Sponsor and/or PI <a href="http://45.79.161.190:8080/attachments/export/1736">click here</a> <a href="/attachments/download/2277">screenshot_9.png</a> dated 11th July 2025 Version 1 11. Signed investigator(s) CV(s) including that of study Pharmacist (NB: The CV should include the current workload of the Principal Investigator ) <a href="/attachments/download/2278">screenshot_10.png</a> dated 11th July 2025 Version 1 12. GMP certificate of the investigational product from the site of manufacture <a href="/attachments/download/2279">screenshot_11.png</a> dated 11th July 2025 Version 1 13. Investigators Brochure/Package inserts <a href="/attachments/download/2280">screenshot_12.png</a> dated 11th July 2025 Version 3 </div> After review of the documents, the Pharmacy and Poisons Board Expert Committee on Clinical Trials notes the following: :reviewer_summary_comments The Pharmacy and Poisons Board Expert Committee on Clinical Trials grants approval to the study: Test ECCT/25/07/01. This approval is valid for one year and in case the study extends beyond one year from the date of this letter, you are required to seek approval before proceeding with the study. The expiry date is 30th September 2026 <ol> <li> You should ensure compliance with Kenya Legal, regulatory and GCP requirements</li> <li> All safety reports should be submitted to ECCT as per the current PPB clinical trials guidelines</li> <li> It is your responsibility to inform the PPB of any changes to the protocol, research design and procedures that could introduce new or more than minimum risk to human subjects</li> <li> You are also reminded that upon conclusion of the study, you shall be required to submit the executive summary report of the study within 30 days while a copy of the clinical study report in ICH E3 format should be submitted to us within 180 days of the study closure.</li> </ol> <div> Yours Sincerely, </div> :signature :approver For Chief Executive Officer 
 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
 approvermanager
 approval_date04-02-2026
 expiry_date04-02-2027
 statussubmitted
 deleted0
 deleted_date(null)
 created2026-02-04 08:35:50
 modified2026-02-04 08:35:50
 AmendmentLetter(array)
 0(array)
 id21
 application_id231
 approval_noPPB/ECCT/25/07/01/2025(1)
 content<h3 style="text-align: center;"> <img height="86" src="https://lh7-us.googleusercontent.com/eOWVvo3AHW74GguHveDaqdgy3YwNZqOqOO0QtscRoV4hJfcvt8Q6v4oLN3beVNvClvoD1ncu1RhB5D4iuAY-5R9h1aD2lEGqUorBVcQ0azfxsdvIz-WhbF3rA9-VQomtusnP2bNZTuYLFTC6vQ46nQ" style="background-color: transparent; color: rgb(0, 0, 0); font-family: "Bookman Old Style", serif; font-size: 11pt; white-space-collapse: preserve; margin-left: 0px; margin-top: 0px;" width="116" /></h3> MINISTRY OF HEALTH PHARMACY AND POISONS BOARD <table style="width: 100%; border:0px"> <tbody> <tr> <td style="width: 33.33%; border:0px"> <div id="left-editor"> Telegram: "MINHEALTH", Nairobi Cell phone: 0709 770 100 Email: info@pharmacyboardkenya.org Website: web.pharmacyboardkenya.org </div> </td> <td style="width: 33.33%;border:0px"> </td> <td style="width: 33.33%;border:0px"> <div id="right-editor"> Pharmacy and Poisons Board House Along Lenana Road P.O. Box 27663-00506 NAIROBI 17th February 2026 </div> </td> </tr> </tbody> </table> Dear Sir/Madam, Re: ECCT/25/07/01 : Amendment Approval; Sample sample . Reference is made to the above study. We acknowledge receipt of the following documents; <div style="margin-left: 15px;"> 1. Cover letter <a href="http://45.79.161.190:8080/attachments/download/2305">screen_1.png</a> dated 17th February 2026 Version 1 2. Additional Files 1. Test file 1: <a href="http://45.79.161.190:8080/attachments/download/2303">screen_2.png</a> dated 17th February 2026 Version 1 2. Test file 2: <a href="http://45.79.161.190:8080/attachments/download/2304">screen_2_2.png</a> dated 17th February 2026 Version 1 </div> After review of the documents, the Pharmacy and Poisons Board Expert Committee on Clinical Trials grants amendment approval to the study Sample sample . (ECCT/25/07/01). Yours Sincerely, :signature :approver For Chief Executive Officer 
 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
 approvermanager
 approval_date2026-02-17
 expiry_date2026-09-30
 status1
 submitted1
 deleted0
 deleted_date(null)
 created2026-02-17 10:49:27
 modified2026-02-17 10:49:46
 AmendmentApproval(array)
 0(array)
 id31
 application_id231
 approval_no(null)
 amendment1
 contentmanager
 approver(null)
 approval_date17-02-2026
 statusapproved
 deleted0
 deleted_date(null)
 created2026-02-17 10:49:26
 modified2026-02-17 10:49:26
 AmendmentApprovalSummary(empty)
 Organization(array)
 0(array)
 id56
 application_id231
 organization
 contact_person
 address
 telephone_number
 all_tasks
 monitoring
 regulatory
 investigator_recruitment
 ivrs_treatment_randomisation
 data_management
 e_data_capture
 susar_reporting
 quality_assurance_auditing
 statistical_analysis
 medical_writing
 other_duties
 other_duties_specify
 misc(null)
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 SiteDetail(array)
 0(array)
 id205
 application_id231
 county_id(null)
 site_name
 physical_address
 contact_details
 contact_person
 site_capacity(null)
 misc(null)
 created2013-10-18 13:57:09
 modified2025-07-11 17:33:23
 Placebo(array)
 0(array)
 id56
 application_id231
 placebo_present(null)
 pharmaceutical_form
 route_of_administration
 composition
 identical_indp
 major_ingredients
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 Sponsor(array)
 0(array)
 id56
 application_id231
 sponsorsample sample
 sponsor_typeIndustry
 contact_person
 addresssample
 telephone_number07005439282
 fax_number
 cell_number07005439292
 email_addresssample@gmail.com
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 SiteInspection(array)
 0(array)
 id61
 application_id231
 user_id2
 reference_noSI/2025/06
 study_title Sample sample
 protocol_noECCT/25/07/01
 version_no(null)
 pactr_number(null)
 trial_phaseHuman pharmacology (Phase I) : First administration to humans Therapeutic exploratory (Phase II)
 investigatorssample sample sample sample Tel: 0700543987 Email: sample@gmail.com
 co_investigators1 Kiprotich Japheth Email: itsjkiprotich@gmail.com
 study_stage(null)
 inspection_countryKenya
 inspector_names(null)
 inspection_dates(null)
 site_address(null)
 sponsor_address(null)
 lab_address(null)
 events_summary(null)
 conclusiontest
 summary_reporttest
 outcomeFailed Inspection
 approved0
 summary_approved1
 approved_by(null)
 sent_to_pi0
 deleted0
 deleted_date(null)
 created2025-12-11 09:30:55
 modified2026-02-03 12:32:18
 1(array)
 id62
 application_id231
 user_id2
 reference_noSI/2026/01
 study_title Sample sample
 protocol_noECCT/25/07/01
 version_no(null)
 pactr_number(null)
 trial_phaseHuman pharmacology (Phase I) : First administration to humans Therapeutic exploratory (Phase II)
 investigatorssample sample sample sample Tel: 0700543987 Email: sample@gmail.com
 co_investigators1 Kiprotich Japheth Email: itsjkiprotich@gmail.com
 study_stage(null)
 inspection_countryKenya
 inspector_names(null)
 inspection_dates(null)
 site_address(null)
 sponsor_address(null)
 lab_address(null)
 events_summary(null)
 conclusiontest
 summary_reporttest
 outcomePassed
 approved0
 summary_approved1
 approved_by(null)
 sent_to_pi0
 deleted0
 deleted_date(null)
 created2026-02-03 12:33:41
 modified2026-02-03 12:34:25
 2(array)
 id63
 application_id231
 user_id2
 reference_noSI/2026/02
 study_title Sample sample
 protocol_noECCT/25/07/01
 version_no(null)
 pactr_number154
 trial_phaseConsequatur tempora temporibus ipsum sint quia Nam est non voluptate eligendi iste hic unde
 investigatorsEa ullam aut praesen
 co_investigatorsVeniam quibusdam ve
 study_stageBefore trial commencement
 inspection_countryAccusantium iure exe
 inspector_namesFugit consectetur c
 inspection_datesDolore elit archite
 site_addressAut nemo quod do inc
 sponsor_addressMollitia dolor labor
 lab_addressVoluptatem sunt do
 events_summaryVelit praesentium li
 conclusionSite did not meet criteria!
 summary_report(null)
 outcomeFailed Inspection
 approved1
 summary_approved0
 approved_by(null)
 sent_to_pi0
 deleted0
 deleted_date(null)
 created2026-02-03 12:35:45
 modified2026-02-03 12:37:59
 Sae(empty)
 Ciom(array)
 0(array)
 id21
 application_id231
 reference_no(null)
 user_id29
 reporter_emailitsjkiprotich@gmail.com
 e2b_content
 e2b_file(null)
 file/var/www/ctr/app/webroot/media/transfer/gen/ppb70081570_usprd123_20250717062623.xml
 dirnamegen
 basenameppb70081570_usprd123_20250717062623.xml
 checksum65994917bcdae5285d73d8fb02d272fd
 alternative(null)
 group(null)
 descriptionTest sample
 created2025-07-17 16:40:03
 modified2025-07-17 16:40:03
 deleted(null)
 1(array)
 id22
 application_id231
 reference_no(null)
 user_id29
 reporter_emailitsjkiprotich@gmail.com
 e2b_content
 e2b_file(null)
 file/var/www/ctr/app/webroot/media/transfer/gen/test.xml
 dirnamegen
 basenametest.xml
 checksum490510971792637bae9aa5be1057e922
 alternative(null)
 group(null)
 descriptiontest
 created2025-07-21 12:23:01
 modified2025-07-21 12:23:01
 deleted(null)
 2(array)
 id23
 application_id231
 reference_no(null)
 user_id29
 reporter_emailitsjkiprotich@gmail.com
 e2b_content
 e2b_file(null)
 file/var/www/ctr/app/webroot/media/transfer/gen/ppb70081570_usprd123_20250717062623latest.xml
 dirnamegen
 basenameppb70081570_usprd123_20250717062623latest.xml
 checksum65994917bcdae5285d73d8fb02d272fd
 alternative(null)
 group(null)
 descriptiontest
 created2025-07-21 12:24:26
 modified2025-07-21 12:24:26
 deleted(null)
 StudyRoute(array)
 0(array)
 id542
 application_id231
 study_routeendosinusial
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 Manufacturer(array)
 0(array)
 id56
 application_id231
 manufacturer_namesample
 addresssample
 manufacturer_countryBurundi
 manufacturer_phone0700432874
 manufacturer_emailtest@gmail.com
 manufacturing_activitiesQuality testing
 other_specify
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 Reassignment(empty)
 Attachment(array)
 0(array)
 id2287
 modelApplication
 file/var/www/ctr/app/webroot/media/transfer/gen/wow.webp
 foreign_key231
 dirnamegen
 basenamewow.webp
 checksumf8839c60c387329367d6059e74f0a5fe
 alternative(null)
 groupattachment
 descriptiontest
 year(null)
 file_date(null)
 pocket_name(null)
 version_no(null)
 created2025-12-11 10:31:01
 modified2025-12-11 10:31:11
 pathgen/wow.webp
 AnnualApproval(array)
 0(array)
 id2288
 modelAnnualApproval
 file/var/www/ctr/app/webroot/media/transfer/doc/web_app_backend_development_practical_1.pdf
 foreign_key231
 dirnamedoc
 basenameweb_app_backend_development_practical_1.pdf
 checksumad33433ca1da928ecff93f4744480399
 alternative(null)
 groupcover_letter
 descriptionCover Letter (Should list all the submitted documents, their version numbers and dates)
 year2026
 file_date22-01-2026
 pocket_namecover_letter
 version_no1
 created2026-01-22 10:39:57
 modified2026-01-22 10:39:57
 pathdoc/web_app_backend_development_practical_1.pdf
 AmendmentChecklist(array)
 0(array)
 id2303
 modelAmendmentChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screen_2.png
 foreign_key231
 dirnameimg
 basenamescreen_2.png
 checksum764fd168c1c3dd0a34e6439270edb99b
 alternative(null)
 groupamendment
 descriptionTest file 1
 year1
 file_date2026-02-17
 pocket_name(null)
 version_no1
 created2026-02-17 10:46:50
 modified2026-02-17 10:47:08
 pathimg/screen_2.png
 1(array)
 id2304
 modelAmendmentChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screen_2_2.png
 foreign_key231
 dirnameimg
 basenamescreen_2_2.png
 checksum764fd168c1c3dd0a34e6439270edb99b
 alternative(null)
 groupamendment
 descriptionTest file 2
 year1
 file_date2026-02-17
 pocket_name(null)
 version_no1
 created2026-02-17 10:46:55
 modified2026-02-17 10:47:09
 pathimg/screen_2_2.png
 2(array)
 id2305
 modelAmendmentChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screen_1.png
 foreign_key231
 dirnameimg
 basenamescreen_1.png
 checksumc389e43d57b68f990dc0cebbfbb97dfd
 alternative(null)
 groupamendment_cover_letter
 descriptionCover letter
 year1
 file_date2026-02-17
 pocket_nameamendment_cover_letter
 version_no1
 created2026-02-17 10:47:21
 modified2026-02-17 10:47:21
 pathimg/screen_1.png
 Reminder(empty)
 ParticipantFlow(array)
 0(array)
 id1
 application_id231
 year2025
 original_subjects3
 consented3
 screened3
 enrolled3
 lost3
 lost_reason3
 withdrawn3
 withdrawal_reason3
 self_withdrawal3
 self_withdrawal_reasons3
 active_subjects3
 completed_number3
 created2025-12-11 10:35:46
 modified2025-12-11 10:35:46
 1(array)
 id2
 application_id231
 year2009
 original_subjects640
 consented127
 screened604
 enrolled114
 lost874
 lost_reasonNulla est blanditiis
 withdrawn370
 withdrawal_reasonAt illo debitis quia
 self_withdrawal296
 self_withdrawal_reasonsCommodo accusamus mo
 active_subjects190
 completed_number471
 created2025-12-11 10:36:04
 modified2025-12-11 10:36:04
 2(array)
 id3
 application_id231
 year2025
 original_subjects441
 consented237
 screened453
 enrolled479
 lost224
 lost_reasonQui laboris qui eos
 withdrawn5
 withdrawal_reasonEius non consequatur
 self_withdrawal704
 self_withdrawal_reasonsMolestiae labore qui
 active_subjects841
 completed_number240
 created2025-12-11 10:37:00
 modified2025-12-11 10:37:00
 Budget(array)
 0(array)
 id56
 application_id231
 year(null)
 budget_period(null)
 personnel_currencyKES
 personnel1
 transport_currencyKES
 transport1
 field_currencyKES
 field1
 supplies_currencyKES
 supplies1
 pharmacy_currencyKES
 pharmacy1
 travel_currencyKES
 travel1
 regulatory_currencyKES
 regulatory1
 it_currencyKES
 it1
 lab_currency(null)
 lab(null)
 others_currencyKES
 others1
 kemri_currency(null)
 kemri(null)
 wrair_currency(null)
 wrair(null)
 subject_currencyKES
 subject1
 grand_currencyKES
 grand_total1
 study_information1
 personnel_kshs1
 transport_kshs1
 field_kshs1
 supplies_kshs1
 pharmacy_kshs1
 travel_kshs1
 regulatory_kshs1
 it_kshs1
 lab_kshs(null)
 others_kshs1
 grand_total_kshs1
 subject_kshs1
 created2025-03-27 12:54:56
 modified2025-07-11 17:33:23
 Deviation(array)
 0(array)
 id40
 application_id231
 user_id29
 reference_noDEV/2025/02
 study_title Sample sample
 deviation_type(null)
 deviation_type_dev(null)
 pi_nameKiprotich Keter Japheth
 deviation_date(null)
 participant_number(null)
 treating_physician(null)
 deviation_description(null)
 deviation_explanation(null)
 deviation_measures(null)
 deviation_preclude(null)
 sponsor_notified0
 sponsor_notification_date(null)
 sponsor_explanation(null)
 study_impact(null)
 statusUnsubmitted
 date_submitted(null)
 deleted0
 deleted_date(null)
 created2025-12-11 10:39:44
 modified2025-12-11 10:39:44
 1(array)
 id41
 application_id231
 user_id29
 reference_noDEV/2026/01
 study_title Sample sample
 deviation_typeDeviation
 deviation_type_dev
 pi_nameJasper Massey
 deviation_date23-02-2016
 participant_number29
 treating_physicianFacilis ipsum saepe aut molestiae ut
 deviation_descriptionEnim quibusdam exerc
 deviation_explanationSunt dolore archite
 deviation_measuresEx nostrum ut neque
 deviation_precludeEt proident ut dolo
 sponsor_notified1
 sponsor_notification_date12/31/1982
 sponsor_explanation(null)
 study_impactAnimi exercitatione
 statusSubmitted
 date_submitted(null)
 deleted0
 deleted_date(null)
 created2026-02-04 07:57:29
 modified2026-02-04 08:20:24
 Document(array)
 0(array)
 id2286
 modelApplication
 file/var/www/ctr/app/webroot/media/transfer/doc/suitability_interview_evaluation_charity_mutunga_with_examples.docx
 foreign_key231
 dirnamedoc
 basenamesuitability_interview_evaluation_charity_mutunga_with_examples.docx
 checksum823005f5f8b20fde155adbe8eef42f93
 alternative(null)
 groupdocument
 descriptiontest
 year(null)
 file_date(null)
 pocket_name(null)
 version_no(null)
 created2025-09-30 16:43:19
 modified2025-09-30 16:43:24
 pathdoc/suitability_interview_evaluation_charity_mutunga_with_examples.docx
 CoverLetter(empty)
 Protocol(empty)
 PatientLeaflet(empty)
 Brochure(empty)
 GmpCertificate(empty)
 Cv(empty)
 Finance(empty)
 Declaration(empty)
 IndemnityCover(empty)
 OpinionLetter(empty)
 ApprovalLetter(empty)
 Statement(empty)
 ParticipatingStudy(empty)
 Addendum(empty)
 Registration(empty)
 Fee(empty)
 Checklist(array)
 0(array)
 id1854
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/gen/24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp
 foreign_key231
 dirnamegen
 basename24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp
 checksum8f1396fb0525c55c165b21c9963073f4
 alternative(null)
 groupapplicant_covering_letter
 descriptionCover Letter (Should list all the submitted documents, their version numbers and dates) *
 year(null)
 file_date(null)
 pocket_nameapplicant_covering_letter
 version_no
 created2025-03-27 12:54:36
 modified2025-07-11 17:33:23
 pathgen/24298267_mteyns0xntawltk3zjy4zwrmotytmq_5.webp
 1(array)
 id1855
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/gen/24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp
 foreign_key231
 dirnamegen
 basename24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp
 checksum8f1396fb0525c55c165b21c9963073f4
 alternative(null)
 groupapplicant_statement
 descriptionA signed statement by the applicant indicating that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading. *
 year(null)
 file_date05-03-2025
 pocket_nameapplicant_statement
 version_no
 created2025-03-27 12:54:53
 modified2025-07-11 17:33:23
 pathgen/24298267_mteyns0xntawltk3zjy4zwrmotytmq_6.webp
 2(array)
 id1856
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/gen/24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp
 foreign_key231
 dirnamegen
 basename24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp
 checksum8f1396fb0525c55c165b21c9963073f4
 alternative(null)
 groupapplicant_fees
 descriptionPayment of fees *
 year(null)
 file_date20-03-2025
 pocket_nameapplicant_fees
 version_no
 created2025-03-27 13:18:55
 modified2025-03-27 13:18:55
 pathgen/24298267_mteyns0xntawltk3zjy4zwrmotytmq_7.webp
 3(array)
 id2224
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_from_2025_04_10_06_44_36_5.png
 foreign_key231
 dirnameimg
 basenamescreenshot_from_2025_04_10_06_44_36_5.png
 checksum5008df556372400283c7c6871aed3c00
 alternative(null)
 groupapplicant_protocol
 descriptionThe Study Protocol *
 year(null)
 file_date(null)
 pocket_nameapplicant_protocol
 version_no
 created2025-04-10 07:48:56
 modified2025-04-10 07:48:56
 pathimg/screenshot_from_2025_04_10_06_44_36_5.png
 4(array)
 id2225
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_from_2025_04_10_06_44_36_6.png
 foreign_key231
 dirnameimg
 basenamescreenshot_from_2025_04_10_06_44_36_6.png
 checksum5008df556372400283c7c6871aed3c00
 alternative(null)
 groupapplicant_patient_information
 descriptionPatient Information leaflet and Informed consent form *
 year(null)
 file_date(null)
 pocket_nameapplicant_patient_information
 version_no
 created2025-04-10 07:49:05
 modified2025-04-10 07:49:05
 pathimg/screenshot_from_2025_04_10_06_44_36_6.png
 5(array)
 id2226
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_from_2025_04_10_06_44_36_7.png
 foreign_key231
 dirnameimg
 basenamescreenshot_from_2025_04_10_06_44_36_7.png
 checksum5008df556372400283c7c6871aed3c00
 alternative(null)
 groupapplicant_pan_african
 descriptionRegistration of the study at Pan African Clinical Trials Registry https://pactr.samrc.ac.za *
 year(null)
 file_date10-04-2025
 pocket_nameapplicant_pan_african
 version_no
 created2025-04-10 07:49:19
 modified2025-04-10 07:49:19
 pathimg/screenshot_from_2025_04_10_06_44_36_7.png
 6(array)
 id2272
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_4.png
 foreign_key231
 dirnameimg
 basenamescreenshot_4.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_fees
 descriptionPayment of fees *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_fees
 version_no1
 created2025-07-11 17:31:31
 modified2025-07-11 17:31:31
 pathimg/screenshot_4.png
 7(array)
 id2273
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_5.png
 foreign_key231
 dirnameimg
 basenamescreenshot_5.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_statement
 descriptionA signed statement by the applicant indicating that all information contained in, or referenced by, the application is complete and accurate and is not false or misleading. *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_statement
 version_no1
 created2025-07-11 17:31:35
 modified2025-07-11 17:31:35
 pathimg/screenshot_5.png
 8(array)
 id2274
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_6.png
 foreign_key231
 dirnameimg
 basenamescreenshot_6.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_opinion_letter
 descriptionCopy of favorable opinion letter from the local Ethics Review Committee (ERC). *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_opinion_letter
 version_no1
 created2025-07-11 17:31:38
 modified2025-07-11 17:31:38
 pathimg/screenshot_6.png
 9(array)
 id2275
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_7.png
 foreign_key231
 dirnameimg
 basenamescreenshot_7.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_indemnity_cover
 descriptionClinical Trials Insurance cover for study participants *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_indemnity_cover
 version_no1
 created2025-07-11 17:31:43
 modified2025-07-11 17:31:43
 pathimg/screenshot_7.png
 10(array)
 id2276
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_8.png
 foreign_key231
 dirnameimg
 basenamescreenshot_8.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_signed_declaration
 descriptionSigned Declaration by Sponsor or Principal investigator that the study will be carried out according to the protocol and applicable laws, regulations and GCP requirements. click here *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_signed_declaration
 version_no1
 created2025-07-11 17:31:48
 modified2025-07-11 17:31:48
 pathimg/screenshot_8.png
 11(array)
 id2277
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_9.png
 foreign_key231
 dirnameimg
 basenamescreenshot_9.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_financial_declaration
 descriptionFinancial declaration by Sponsor and/or PI click here *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_financial_declaration
 version_no1
 created2025-07-11 17:31:51
 modified2025-07-11 17:31:51
 pathimg/screenshot_9.png
 12(array)
 id2278
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_10.png
 foreign_key231
 dirnameimg
 basenamescreenshot_10.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_investigators_cv
 descriptionSigned investigator(s) CV(s) including that of study Pharmacist (NB: The CV should include the current workload of the Principal Investigator ) *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_investigators_cv
 version_no1
 created2025-07-11 17:31:57
 modified2025-07-11 17:31:57
 pathimg/screenshot_10.png
 13(array)
 id2279
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_11.png
 foreign_key231
 dirnameimg
 basenamescreenshot_11.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_gmp_certificate
 descriptionGMP certificate of the investigational product from the site of manufacture *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_gmp_certificate
 version_no1
 created2025-07-11 17:32:00
 modified2025-07-11 17:32:00
 pathimg/screenshot_11.png
 14(array)
 id2280
 modelChecklist
 file/var/www/ctr/app/webroot/media/transfer/img/screenshot_12.png
 foreign_key231
 dirnameimg
 basenamescreenshot_12.png
 checksum58862210a28fff1dd0a3866923eb3d8f
 alternative(null)
 groupapplicant_investigators_brochure
 descriptionInvestigators Brochure/Package inserts *
 year(null)
 file_date11-07-2025
 pocket_nameapplicant_investigators_brochure
 version_no3
 created2025-07-11 17:32:08
 modified2025-07-11 17:32:08
 pathimg/screenshot_12.png
 StudyMonitor(empty)
 ProtocolOutsource(empty)
 Outsource(array)
 0(array)
 id9
 application_id231
 user_id(null)
 model
 usernameits.jkipro.tich
 nameKiprotich Keter Japheth
 emailits.jkipro.tich@gmail.com
 phone_no0724743788
 institution_physicalsample
 name_of_institutionTest
 institution_addresssome address
 institution_contact0700543872
 county_id3
 country_id115
 approved0
 created2025-08-08 12:00:28
 modified2025-08-08 12:00:28
 accepted(null)
 model_sae0
 model_ciom0
 model_dev1
 1(array)
 id10
 application_id231
 user_id(null)
 model
 usernameitsjkiprotich
 nameKiprotich Keter Japheth
 emailitsjkiprotich@gmail.com
 phone_no0724743789
 institution_physicalsample
 name_of_institutionKiprotich Keter Japheth
 institution_address
 institution_contact
 county_id2
 country_id115
 approved0
 created2025-08-08 12:06:15
 modified2025-08-08 12:06:15
 accepted(null)
 model_sae0
 model_ciom0
 model_dev1
 2(array)
 id11
 application_id231
 user_id848
 model
 usernamekiprotich.japheth19
 nameKiprotich Keter Japheth
 emailkiprotich.japheth19@gmail.com
 phone_no0724743788
 institution_physicalsample
 name_of_institutionKiprotich Keter Japheth
 institution_addresssome address
 institution_contact0700543872
 county_id2
 country_id115
 approved1
 created2025-08-08 12:14:09
 modified2025-08-08 12:14:57
 accepted(null)
 model_sae1
 model_ciom0
 model_dev0
- redir
- $request->data(empty)
- $this->validationErrors(array)
 Permission(empty)
 Aro(empty)
 Aco(empty)
 Application(empty)
 User(empty)
 TrialStatus(empty)
 Review(empty)
 InternalReview(empty)
 ActiveInspector(empty)
 ManagerReview(empty)
 Acceptance(empty)
 Amendment(empty)
 InvestigatorContact(empty)
 ApplicationStage(empty)
 Pharmacist(empty)
 EthicalCommittee(empty)
 AnnualLetter(empty)
 AmendmentLetter(empty)
 AmendmentApproval(empty)
 AmendmentApprovalSummary(empty)
 Organization(empty)
 SiteDetail(empty)
 Placebo(empty)
 Sponsor(empty)
 SiteInspection(empty)
 Sae(empty)
 Ciom(empty)
 StudyRoute(empty)
 Manufacturer(empty)
 Reassignment(empty)
 Attachment(empty)
 AnnualApproval(empty)
 AmendmentChecklist(empty)
 Reminder(empty)
 ParticipantFlow(empty)
 Budget(empty)
 Deviation(empty)
 Document(empty)
 CoverLetter(empty)
 Protocol(empty)
 PatientLeaflet(empty)
 Brochure(empty)
 GmpCertificate(empty)
 Cv(empty)
 Finance(empty)
 Declaration(empty)
 IndemnityCover(empty)
 OpinionLetter(empty)
 ApprovalLetter(empty)
 Statement(empty)
 ParticipatingStudy(empty)
 Addendum(empty)
 Registration(empty)
 Fee(empty)
 Checklist(empty)
 StudyMonitor(empty)
 ProtocolOutsource(empty)
 Outsource(empty)
- Loaded Helpers(array)
 0Html
 1Form
 2Session
 3Text
 4Number
 5SimpleGraph
 6DebugTimer
 7Toolbar
 8HtmlToolbar
====

Environment

App Constants

Constant	Value
MEDIA	'/var/www/ctr/app/webroot/media/'
MEDIA_STATIC	'/var/www/ctr/app/webroot/media/static/'
MEDIA_FILTER	'/var/www/ctr/app/webroot/media/filter/'
MEDIA_TRANSFER	'/var/www/ctr/app/webroot/media/transfer/'
MEDIA_URL	'media/'
MEDIA_STATIC_URL	'media/static/'
MEDIA_FILTER_URL	'media/filter/'
MEDIA_TRANSFER_URL	'media/transfer/'
HTTP_HOST	'45.79.161.190:8080'
HTTP_BASE	'http://45.79.161.190:8080'
HTTP_SELF	'/app/webroot/index.php'
HTTP_URI	'/applications/view/231'
CHOWN_PUBLIC	(int) 504
LF	''
NL	''
CR	''
TB	''
BR	' '
WINDOWS	false
FORMAT_DB_DATETIME	'Y-m-d H:i:s'
FORMAT_DB_DATE	'Y-m-d'
FORMAT_DB_TIME	'H:i:s'
DEFAULT_DATETIME	'0000-00-00 00:00:00'
DEFAULT_DATE	'0000-00-00'
DEFAULT_TIME	'00:00:00'
FILES	'/var/www/ctr/app/files/'
LOCALE	'/var/www/ctr/app/locale/'
CLASS_USER	'User'
VALID_ALPHA	'/^[a-zA-Z]+$/'
VALID_ALPHA_UNDERSCORES	'/^[a-zA-Z_]+$/'
VALID_ALPHA_MINUS_UNDERSCORES	'/^[a-zA-Z_-]+$/'
VALID_ALPHA_WHITESPACES	'/^[a-zA-Z ]+$/'
VALID_ALPHANUMERIC_UNDERSCORES	'/^[\da-zA-Z_]+$/'
VALID_ALPHANUMERIC_MINUS_UNDERSCORES	'/^[\da-zA-Z_-]+$/'
VALID_ALPHANUMERIC_WHITESPACES	'/^[\da-zA-Z ]+$/'
VALID_ALPHANUMERIC_WHITESPACES_UNDERSCORES	'/^[\da-zA-Z _]+$/'
VALID_NUMERIC_UNDERSCORES	'/^[\d_]+$/'
VALID_NUMERIC_WHITESPACES	'/^[\d ]+$/'
VALID_NUMERIC_WHITESPACES_UNDERSCORES	'/^[\d _]+$/'
VALID_INTEGERS	'/^[\d]+$/'
FORMAT_NICE_YMDHMS	'd.m.Y, H:i:s'
FORMAT_NICE_YMDHM	'd.m.Y, H:i'
FORMAT_NICE_YM	'm.Y'
FORMAT_NICE_YMD	'd.m.Y'
FORMAT_NICE_MD	'd.m.'
FORMAT_NICE_D	'd'
FORMAT_NICE_W_NUM	'w'
FORMAT_NICE_W_ABBR	'D'
FORMAT_NICE_W_FULL	'l'
FORMAT_NICE_M	'm'
FORMAT_NICE_M_ABBR	'M'
FORMAT_NICE_M_FULL	'F'
FORMAT_NICE_Y_ABBR	'y'
FORMAT_NICE_Y	'Y'
FORMAT_NICE_HM	'H:i'
FORMAT_NICE_HMS	'H:i:s'
FORMAT_LOCAL_WA_YMDHMS	'%a, %d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_WF_YMDHMS	'%A, %d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_WA_YMDHM	'%a, %d.%m.%Y, %H:%M'
FORMAT_LOCAL_WF_YMDHM	'%A, %d.%m.%Y, %H:%M'
FORMAT_LOCAL_YMDHMS	'%d.%m.%Y, %H:%M:%S'
FORMAT_LOCAL_YMDHM	'%d.%m.%Y, %H:%M'
FORMAT_LOCAL_YMD	'%d.%m.%Y'
FORMAT_LOCAL_MD	'%d.%m.'
FORMAT_LOCAL_D	'%d'
FORMAT_LOCAL_W_NUM	'%w'
FORMAT_LOCAL_W_ABBR	'%a'
FORMAT_LOCAL_W_FULL	'%A'
FORMAT_LOCAL_M	'%m'
FORMAT_LOCAL_M_ABBR	'%b'
FORMAT_LOCAL_M_FULL	'%B'
FORMAT_LOCAL_Y_ABBR	'%y'
FORMAT_LOCAL_YMS_ABBR	'%d.%m.%y'
FORMAT_LOCAL_Y	'%Y'
FORMAT_LOCAL_H	'%H'
FORMAT_LOCAL_S	'%S'
FORMAT_LOCAL_HM	'%H:%M'
FORMAT_LOCAL_HMS	'%H:%M:%S'
CHAR_LESS	'<'
CHAR_GREATER	'>'
CHAR_QUOTE	'"'
CHAR_APOSTROPHE	'''
CHAR_ARROWS	'»'
CHAR_ARROWS_R	'»'
CHAR_ARROWS_L	'«'
CHAR_AVERAGE	'Ø'
CHAR_INFIN	'∞'
CHAR_MILL	'‰'
CHAR_PLUSMN	'±'
CHAR_HELLIP	'…'
CHAR_CIRCA	'≈'
CHAR_CHECKBOX_EMPTY	'☐]'
CHAR_CHECKBOX_MAKRED	'☑'
CHAR_CHECKMARK	'✓'
CHAR_CHECKMARK_BOLD	'✔'
CHAR_BALLOT	'✗'
CHAR_BALLOT_BOLD	'✘'
CHAR_ABOUT	'≈'
CHAR_RPIME	'′'
CHAR_DOUBLE_RPIME	'″'

CakePHP Constants

Constant	Value
APP	'/var/www/ctr/app/'
APP_DIR	'app'
APPLIBS	'/var/www/ctr/app/Lib/'
CACHE	'/var/www/ctr/app/tmp/cache/'
CAKE	'/var/www/ctr/lib/Cake/'
CAKE_CORE_INCLUDE_PATH	'/var/www/ctr/lib'
CORE_PATH	'/var/www/ctr/lib/'
CAKE_VERSION	'2.2.2'
CSS	'/var/www/ctr/app/webroot/css/'
CSS_URL	'css/'
DS	'/'
FULL_BASE_URL	'http://45.79.161.190:8080'
IMAGES	'/var/www/ctr/app/webroot/img/'
IMAGES_URL	'img/'
JS	'/var/www/ctr/app/webroot/js/'
JS_URL	'js/'
LOGS	'/var/www/ctr/app/tmp/logs/'
ROOT	'/var/www/ctr'
TESTS	'/var/www/ctr/app/Test/'
TMP	'/var/www/ctr/app/tmp/'
VENDORS	'/var/www/ctr/vendors/'
WEBROOT_DIR	'webroot'
WWW_ROOT	'/var/www/ctr/app/webroot/'

PHP Environment

Environment Variable	Value
Php Version	'5.6.40-63+ubuntu18.04.1+deb.sury.org+2'
Redirect Redirect Status	'200'
Redirect Status	'200'
Http Accept	'/'
Http User Agent	'Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)'
Http Accept Encoding	'gzip, br, zstd, deflate'
Http Host	'45.79.161.190:8080'
Http Via	'1.1 squid-proxy-5b5d847c96-zcnbk (squid/6.13)'
Http X Forwarded For	'10.1.226.34'
Http Cache Control	'max-age=259200'
Http Connection	'keep-alive'
Path	'/usr/local/sbin:/usr/local/bin:/usr/sbin:/usr/bin:/sbin:/bin:/snap/bin'
Server Signature	' Apache/2.4.29 (Ubuntu) Server at 45.79.161.190 Port 8080 '
Server Software	'Apache/2.4.29 (Ubuntu)'
Server Name	'45.79.161.190'
Server Addr	'45.79.161.190'
Server Port	'8080'
Remote Addr	'216.73.216.151'
Document Root	'/var/www/ctr'
Request Scheme	'http'
Context Prefix	''
Context Document Root	'/var/www/ctr'
Server Admin	'webmaster@localhost'
Script Filename	'/var/www/ctr/app/webroot/index.php'
Remote Port	'60810'
Redirect Url	'/app/webroot/applications/view/231'
Gateway Interface	'CGI/1.1'
Server Protocol	'HTTP/1.1'
Request Method	'GET'
Query String	''
Request Uri	'/applications/view/231'
Script Name	'/app/webroot/index.php'
Php Self	'/app/webroot/index.php'
Request Time Float	(float) 1775148626.859
Request Time	(int) 1775148626

====

Include
+
Included Files

Include Paths
- 0/var/www/ctr/app/Plugin/Media/Lib/mm/src
- 1/var/www/ctr/lib
- 3/usr/share/php
- 4-> /var/www/ctr/lib/Cake/
Included Files
- core(array)
  Behavior(array)
  0CORE/Model/Behavior/TreeBehavior.php
  1CORE/Model/Behavior/ContainableBehavior.php
  2CORE/Model/Behavior/AclBehavior.php
  Cache(array)
  0CORE/Cache/Cache.php
  1CORE/Cache/Engine/FileEngine.php
  2CORE/Cache/CacheEngine.php
  Component(array)
  0CORE/Controller/Component/AclComponent.php
  1CORE/Controller/Component/Acl/DbAcl.php
  2CORE/Controller/Component/Acl/AclInterface.php
  3CORE/Controller/Component/AuthComponent.php
  4CORE/Controller/Component/RequestHandlerComponent.php
  5CORE/Controller/Component/SessionComponent.php
  Config(array)
  0CORE/Config/routes.php
  1CORE/Config/config.php
  Controller(array)
  0CORE/Controller/Controller.php
  1CORE/Controller/ComponentCollection.php
  2CORE/Controller/Component.php
  Datasource(array)
  0CORE/Model/Datasource/CakeSession.php
  1CORE/Model/Datasource/Database/Mysql.php
  2CORE/Model/Datasource/DboSource.php
  3CORE/Model/Datasource/DataSource.php
  Error(array)
  0CORE/Error/exceptions.php
  1CORE/Error/ErrorHandler.php
  I18n(array)
  0CORE/I18n/I18n.php
  1CORE/I18n/L10n.php
  Log(array)
  0CORE/Log/CakeLog.php
  1CORE/Log/LogEngineCollection.php
  2CORE/Log/Engine/FileLog.php
  3CORE/Log/Engine/BaseLog.php
  4CORE/Log/CakeLogInterface.php
  Model(array)
  0CORE/Model/ConnectionManager.php
  1CORE/Model/Permission.php
  2CORE/Model/Model.php
  3CORE/Model/BehaviorCollection.php
  4CORE/Model/Aro.php
  5CORE/Model/AclNode.php
  6CORE/Model/Aco.php
  7CORE/Model/ModelBehavior.php
  Network(array)
  0CORE/Network/CakeRequest.php
  1CORE/Network/CakeResponse.php
  Other(array)
  0CORE/bootstrap.php
  1CORE/basics.php
  2CORE/Core/App.php
  3CORE/Core/Configure.php
  4CORE/Core/CakePlugin.php
  5CORE/Event/CakeEventListener.php
  6CORE/Event/CakeEvent.php
  7CORE/Event/CakeEventManager.php
  8CORE/Core/Object.php
  Routing(array)
  0CORE/Routing/Dispatcher.php
  1CORE/Routing/Filter/AssetDispatcher.php
  2CORE/Routing/DispatcherFilter.php
  3CORE/Routing/Filter/CacheDispatcher.php
  4CORE/Routing/Router.php
  5CORE/Routing/Route/CakeRoute.php
  6CORE/Routing/Route/PluginShortRoute.php
  Utility(array)
  0CORE/Utility/Hash.php
  1CORE/Utility/Inflector.php
  2CORE/Utility/ObjectCollection.php
  3CORE/Utility/Debugger.php
  4CORE/Utility/String.php
  5CORE/Utility/ClassRegistry.php
  6CORE/Utility/Set.php
  View(array)
  0CORE/View/HelperCollection.php
- app(array)
  Behavior(array)
  0APP/Model/Behavior/SoftDeleteBehavior.php
  1APP/Model/Behavior/TimestampBehavior.php
  Config(array)
  0APP/Config/core.php
  1APP/Config/bootstrap.php
  2APP/Config/routes.php
  3APP/Config/database.php
  Controller(array)
  0APP/Controller/ApplicationsController.php
  1APP/Controller/AppController.php
  Model(array)
  0APP/Model/AppModel.php
  1APP/Model/Application.php
  2APP/Model/User.php
  3APP/Model/TrialStatus.php
  4APP/Model/Review.php
  5APP/Model/ActiveInspector.php
  6APP/Model/Amendment.php
  7APP/Model/InvestigatorContact.php
  8APP/Model/ApplicationStage.php
  9APP/Model/Pharmacist.php
  10APP/Model/EthicalCommittee.php
  11APP/Model/AnnualLetter.php
  12APP/Model/AmendmentLetter.php
  13APP/Model/AmendmentApproval.php
  14APP/Model/Organization.php
  15APP/Model/SiteDetail.php
  16APP/Model/Placebo.php
  17APP/Model/Sponsor.php
  18APP/Model/SiteInspection.php
  19APP/Model/Sae.php
  20APP/Model/Ciom.php
  21APP/Model/StudyRoute.php
  22APP/Model/Manufacturer.php
  23APP/Model/Reassignment.php
  24APP/Model/Attachment.php
  25APP/Model/Reminder.php
  26APP/Model/ParticipantFlow.php
  27APP/Model/Budget.php
  28APP/Model/Deviation.php
  29APP/Model/StudyMonitor.php
  30APP/Model/ProtocolOutsource.php
  31APP/Model/Outsource.php
  Other(array)
  0APP/webroot/index.php
- plugins(array)
  CakePdf(array)
  Config(array)
  0CakePdf/Config/bootstrap.php
  1CakePdf/Config/routes.php
  CakeResque(array)
  Config(array)
  0CakeResque/Config/bootstrap.php
  Plugin(array)
  0CakeResque/Lib/CakeResque.php
  1CakeResque/vendor/kamisama/php-resque-ex/lib/Resque.php
  2CakeResque/vendor/kamisama/php-resque-ex/lib/Resque/Event.php
  3CakeResque/vendor/kamisama/php-resque-ex/lib/Resque/Exception.php
  DebugKit(array)
  Component(array)
  0DebugKit/Controller/Component/ToolbarComponent.php
  Plugin(array)
  0DebugKit/Lib/DebugMemory.php
  1DebugKit/Lib/Panel/HistoryPanel.php
  2DebugKit/Lib/DebugPanel.php
  3DebugKit/Lib/Panel/SessionPanel.php
  4DebugKit/Lib/Panel/RequestPanel.php
  5DebugKit/Lib/Panel/SqlLogPanel.php
  6DebugKit/Lib/Panel/TimerPanel.php
  7DebugKit/Lib/Panel/LogPanel.php
  8DebugKit/Lib/Log/Engine/DebugKitLog.php
  9DebugKit/Lib/Panel/VariablesPanel.php
  10DebugKit/Lib/Panel/EnvironmentPanel.php
  11DebugKit/Lib/Panel/IncludePanel.php
  12DebugKit/Lib/DebugTimer.php
  Media(array)
  Config(array)
  0Media/Config/bootstrap.php
  Plugin(array)
  0Media/Lib/mm/src/Mime/Type.php
  1Media/Lib/mm/src/Mime/Type/Magic/Adapter/Fileinfo.php
  2Media/Lib/mm/src/Mime/Type/Magic/Adapter.php
  3Media/Lib/mm/src/Mime/Type/Glob/Adapter/Memory.php
  4Media/Lib/mm/src/Mime/Type/Glob/Adapter.php
  5Media/Lib/mm/src/Media/Process.php
  6Media/Lib/mm/src/Media/Info.php
  Behavior(array)
  0Media/Model/Behavior/TransferBehavior.php
  1Media/Model/Behavior/CouplerBehavior.php
  2Media/Model/Behavior/MetaBehavior.php
  Search(array)
  Component(array)
  0Search/Controller/Component/PrgComponent.php
  Behavior(array)
  0Search/Model/Behavior/SearchableBehavior.php
  Shim(array)
  Config(array)
  0Shim/Config/bootstrap.php
  Tools(array)
  Config(array)
  0Tools/Config/bootstrap.php
====

Study Title:	Sample sample
	sample
Study Objectives:	sample sample
3	only option
Laymans Summary:	test
Abstract of Study:	Sample

Request History

Session

Request

Cake Params

Post data

Query string

Cookie

Current Route

Sql Logs

default

Total Time: 49 ms Total Queries: 54 queries

Query Explain:

Memory

Timers

Logs

View Variables

App Constants

CakePHP Constants

PHP Environment

Included Files

Include Paths

Included Files

Total Time: 49 ms
Total Queries: 54 queries